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GENETIC DISCRIMINATION, INSURABILITY
AND LEGISLATION: A CLOSING OF THE
LEGAL LOOPHOLES
Richard A. Bornstein*
Why does this magnificent applied science, which saves
work and makes life easier, bring us so little happiness?
The simple answer runs: Because we have not yet learned
to make sensible use of it.
-Albert Einstein'
INTRODUCTION
Genetic testing is one of the newest methods for predicting a
person's health.2 While genetic tests can be extremely helpful in
preventing disease,3 they can also prevent many people from
. Brooklyn Law School Class of 1997; M.S., Massachusetts Institute of
Technology, 1992; B.A., Brandeis University, 1989. The author wishes to thank
Brooklyn Law School Professor Carrie Teitcher for her valuable assistance in the
preparation of this Note. A special thanks to my wife, Sarah Reines, for her
continuous support. This Note is dedicated to Talia Reines Bornstein, born April
13, 1996.
Address at the California Institute of Technology, in GEORGE SELDES,
GREAT QuOTATIONs 854-55 (1967).
2 "Genetic testing" involves "the use of specific assays [analyses] to
determine the genetic status of individuals already suspected to be at high risk
for a particular inherited condition because of family history or clinical
symptoms," while "genetic screening" denotes "the use of various genetic tests
to evaluate populations or groups of individuals independent of a family history
of a disorder." However, these terms are used interchangeably. AsSESSING
GENETIC RISKS 4 (Lori B. Andrews et al. eds., 1994). See notes and accompany-
ing text infra p. 607 (analyzing the definitions of genetic testing for enacted state
legislation).
3 According to Mark Ferguson, professor of molecular biology at Manchester
University, advances in the mapping of human genes will eventually mean that
people could obtain a "genetic passport" which would tell them what diseases
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obtaining medical insurance because coverage may be denied if
genetic test results reveal a propensity for illness.4 Researchers
have found that a number of institutions, including health and life
insurers, have discriminated on a genetic basis.5 People at risk for
genetic discrimination6 include individuals who carry a gene that
increases the probability that they will develop a disease but who
are currently asymptomatic;7 individuals who are carriers for
certain genetic conditions but who will remain asymptomatic;'
individuals who have genetic polymorphisms9 that are not known
they would likely suffer from in the future. Chris Mihill, Gene Maps of Illness
Risk, GUARDIAN, Sept. 2, 1993, at 6 ("This information would allow a profound
shift towards preventive medicine.., because people could be treated for or take
precautions against the diseases they were at risk of contracting.").
' Genetic Tests Could Help Insurance Firms Discriminate (All Things
Considered-National Public Radio broadcast, June 29, 1995) (transcript No.
1893-15).
' See Susan Ince, Predictive Testing; A Bite of the Apple, HARV. HEALTH
LETTER (Harvard Medical School Health Publications Group, Boston, MA), June
1995, at 3, 4 (discussing predictive testing and problems with discrimination); see
also Paul R. Billings et al., Discrimination as a Consequence of Genetic Testing,
50 AM. J. HUM. GENET. 476 (1992) (describing the results of a case history
study showing that genetic discrimination exists); Marvin R. Natowicz et al.,
Genetic Discrimination and the Law, 50 AM. J. HUM. GENET. 465 (1992)
(discussing genetic discrimination and the applicability and limitations of federal
and state laws in insurance discrimination); Richard Saltus, Fear of Insurers
Leading to Gene Testing in Secret, BOSTON GLOBE, Sept. 12, 1994, at 1
(discussing the denial of health insurance as a result of genetic information).
6 "Genetic discrimination" is defined as "discrimination against an individual
or against members of that individual's family solely because of real or perceived
differences from the 'normal' genome in the genetic constitution of that
individual." Natowicz, supra note 5, at 466. "Genome" refers to all of an
organism's genetic material in its chromosomes. Glossary, in THE CODE OF
CODES 375, 380 (Daniel J. Kevles & Leroy Hood eds., 1992) [hereinafter
Glossary]. See infra note 19 (defining chromosome).
7 Natowicz, supra note 5, at 466. An individual who is asymptomatic has no
disease symptoms. STEDMAN'S MEDICAL DICTIONARY 160 (26th ed. 1995)
[hereinafter MEDICAL DICTIONARY].
Natowicz, supra note 5, at 466.
A "polymorphism" is "the occurrence in a population of two or more
forms of a gene, the least common having a frequence of at least 1%." SHERMAN
ELIAS & GEORGE ANNAS, REPRODUCTIVE GENETICS AND THE LAW 97 (1987).
An example of a human genetic polymorphism is the ABO blood groups. Id.
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to cause disease; and relatives of individuals with known or
presumed genetic characteristics."0
Currently, twelve states have enacted general legislation
restricting genetic testing or the use of genetic information in the
context of insurance practice," and five of these states have
pending legislation to update their genetic testing laws.'2 In
addition, at least fifteen more states have some type of genetic
discrimination legislation proposed. 3
10 Natowicz, supra note 5, at 466.
" ARiz. REv. STAT. ANN. § 20-448 (1990 & Supp. 1995); CAL. CIV. CODE
§ 56.17 (West Supp. 1996); CAL. INS. CODE § 11512.95 (West 1988 & Supp.
1996); CAL. INS. CODE § 10143 (West 1993); CAL. INS. CODE §§ 10123.3,
10140 (West 1993 & Supp. 1996); CAL. INS. CODE §§ 10123.31, 10123.35,
10140.1, 10140.5, 10146, 10147, 10148, 10149, 10149.1, 11512.96, 11512.965
(West Supp. 1996); CAL. HEALTH & SAFETY CODE § 1374.7 (West 1990 &
Supp. 1996); CAL. HEALTH & SAFETY CODE § 1374.9 (West Supp. 1996);
COLO. REv. STAT. ANN. § 10-3-1104.7 (1994); FLA. STAT. ANN. § 760.40 (West
Supp. 1996); GA. CODE ANN. §§ 33-54-1 to 8 (Supp. 1995); MD. CODE ANN.,
INS. § 223 (1994); MINN. STAT. ANN. § 72A.139 (West Supp. 1996); MONT.
CODE ANN. § 33-18-206 (1995); N.H. REv. STAT. ANN. §§ 141-H:l to 6 (Supp.
1995); OHIO REV. CODE ANN. §§ 1742.42,1742.43,3901.49,3901.491,3901.50,
3901.501 (Anderson Supp. 1995); OR. REv. STAT. §§ 659.700,659.705,659.710,
659.715, 659.720, 746.135 (1995); Wis. STAT. ANN. § 631.89 (West 1995).
2 Legislation to update genetic testing laws is pending in California, Florida,
Georgia, Maryland and Wisconsin. See S.B. 1740, 1995-96 Reg. Sess. (Cal.
1995); S.B. 748, 1996 Reg. Sess. (Fla. 1996); H.B. 923, 1996 Reg. Sess. (Fla.
1996) (identical bills); S.B. 233, 143d Gen. Assembly, 1995-96 Reg. Sess. (Ga.
1995); S.B. 276, 1996 Leg. Sess. (Md. 1996); A.B. 227, 92d Leg. Sess., 1995-96
Reg. Sess. (Wis. 1995).
" Genetic testing legislation is pending in fifteen states including Alaska
(H.B. 407, 19th Leg., 2d Sess. (Ala. 1995)), Connecticut (H.B. 5705, 1996 Reg.
Sess. (Conn. 1996)), Hawaii (S.B. 299, 18th Leg., 1995 Reg. Sess. (Haw. 1995);
S.B. 576, 18th Leg., 1995 Reg. Sess. (Haw. 1995); S.B. 2141, 18th Leg., 1995
Reg. Sess. (Haw. 1995); S.B. 2526, 18th Leg., 1995 Reg. Sess. (Haw. 1995);
H.B. 1556, 18th Leg., 1995 Reg. Sess. (Haw. 1995)), Illinois (S.B. 1384, 89th
Gen. Assembly, 1995-96 Reg. Sess. (I11. 1995); H.B. 2943, 89th Gen. Assembly,
1995-96 Reg. Sess. (I11. 1995)), Indiana (H.B. 1200, 109th Gen. Assembly, 2d
Reg. Sess. (Ind. 1996)), Kansas (S.B. 444, 76th Leg., 1996 Reg. Sess. (Kan.
1996); H.B. 2251, 76th Leg., 1st Reg. Sess. (Kan. 1995)), Massachusetts (H.B.
4485, 179th Gen. Court, 1st Annual Sess. (Mass. 1995)), Michigan (H.B. 5237,
88th Leg., 1995 Reg. Sess. (Mich. 1995)), Nebraska (L.B. 1216, 94th Leg., 2d
Sess. (Neb. 1995)), New Jersey (S.B. 695, 207th Leg., 1st Annual Sess. (N.J.
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This Note focuses on the genetic testing legislation. Part I
introduces genetic disorders and new gene discoveries. Parts II and
III discuss genetic discrimination and the weaknesses of using
genetic information for insurance underwriting, respectively. Part
IV examines policy issues of privacy and autonomy, and part V
analyzes the current legislation, including the scope of protection
provided by each law.4 This Note concludes that there is a trend
in the newest enacted laws 5 and in the pending changes to older
1996); S.B. 854, 207th Leg., 1st Annual Sess. (N.J. 1996); A.B. 1411, 207th
Leg., 1st Annual Sess. (N.J. 1996); A.B. 1499, 207th Leg., 1st Annual Sess. (N.J.
1996)), New York (S.B. 15, 218th Gen. Assembly, 1995-96 Reg. Sess. (N.Y.
1995); S.B. 869, 218th Gen. Assembly, 1995-96 Reg. Sess. (N.Y. 1995); S.B.
4293, 219th Gen. Assembly, 1995-96 Reg. Sess. (N.Y. 1995); S.B. 6599, 219th
Gen. Assembly, 2d Reg. Sess. (N.Y. 1996); A.B. 161, 218th Gen. Assembly,
1995-96 Reg. Sess. (N.Y. 1995); A.B. 5796, 219th Gen. Assembly, 1995-96 Reg.
Sess. (N.Y. 1995); A.B. 5892, 218th Gen. Assembly, 1995-96 Reg. Sess. (N.Y.
1995); A.B. 8963, 219th Gen. Assembly, 1995-96 Reg. Sess. (N.Y. 1995); A.B.
9457, 219th Gen. Assembly, 2d Reg. Sess. (N.Y. 1996)), Oklahoma (H.B. 2478,
45th Leg., 2d Reg. Sess. (Okla. 1995)), Pennsylvania (S.R. 6, 179th Gen.
Assembly, 1995-96 Reg. Sess. (Pa. 1995); S.B. 394, 179th Gen. Assembly, 1995-
96 Reg. Sess. (Pa. 1995); S.B. 1386, 180th Gen. Assembly, 1995-96 Reg. Sess.
(Pa. 1995); H.B. 1026, 179th Gen. Assembly, 1995-96 Reg. Sess. (Pa. 1995);
H.B. 1662, 179th Gen. Assembly, 1995-96 Reg. Sess. (Pa. 1995)), Texas (H.B.
343, 74th Reg. Sess. (Tex. 1995)) and Virginia (S.J.R. 50, 1996 Sess. (Va.
1996); S.B. 335, 1996 Sess. (Va. 1996)).
" For instance, Maryland's statute prohibits health and life insurers from
permitting any differential in ratings, premium payments or dividends because
of a genetic trait, but allows consideration if "there is actuarial justification for
it." MD. CODE ANN., INS. § 223(a)(3), (b)(4). See infra part V.B.1 (discussing
Maryland's unfair discrimination statute).
"s See, e.g., CAL. INS. CODE §§ 10123.3, 10123.31, 10123.35, 10140,
10140.1, 10140.5, 10143, 10146, 10147, 10148, 10149, 10149.1, 11512.95,
11512.96, 11512.965; CAL. HEALTH & SAFETY CODE §§ 1374.7, 1374.9; GA.
CODE ANN. §§ 33-54-1 to 8; MINN. STAT. ANN. § 72A.139. See infra part V.C.
(discussing trends in the enacted state laws).
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laws 6 that is moving in a more comprehensive and consumer
protective direction in the area of health insurance.
The enactment of legislation which regulates genetic testing is
necessary and overdue. With the discovery of new genes, the causes
of genetic disorders are now ascertainable.' 7 The majority of states
must recognize that legislation is needed to protect individuals from
denial or loss of insurance due to this information.
I. GENES AND GENETIC DISORDERS' 8
Humans have twenty-three pairs of chromosomes 9 made of
the hereditary material deoxyribonucleic acid ("DNA"),2  which
6 See, e.g., S.B. 748, 1996 Reg. Sess. (Fla. 1996); H.B. 923, 1996 Reg.
Sess. (Fla. 1996). Legislation enacted between 1986 and 1992 focused primarily
on life insurance, and gave little protection to individuals in the area of health
insurance. However, the trend in the law is shifting-between 1993 and 1995,
less emphasis was given to life insurance, and greater protections were estab-
lished for health insurance. See infra part V.C. (discussing trends in the enacted
state laws).
" See infra notes 37-41 (discussing new gene discoveries and causes of
genetic disease).
18 Information on genes and the human genome project is available on the
Internet from the Uniform Resource Locator: http://www.oml.gov/
TechResources/HumanGenome/home.html. "Begun in 1990 by the National
Institutes of Health and the U.S. Department of Energy, the Human Genome
Initiative (HGI) is a 15-year coordinated research endeavor. The goal is to locate
and identify the functions of the 50,000 [to] 100,000 genes that determine human
hereditary characteristics. . . ." Bill Allen & Ray Moseley, Predictive Genetic
Testing: Ethical, Legal, and Social Implications, USA TODAY, Nov. 1994, at 66,
67. See Scientists Finish First Phase in Mapping of Human Genes, N.Y. TIMES,
Mar. 19, 1996, at C7 (discussing two "maps" of DNA recently published); see
also Tim Beardsley, Trends in Human Genetics; Vital Data, 274 Sci. AM. 100
(1996) (discussing the "genetic revolution" and implications of the Human
Genome Project).
"9 A "chromosome" is defined as "[o]ne of the bodies (normally 46 in
humans) in the cell nucleus that is the bearer of genes." MEDICAL DICTIONARY,
supra note 7, at 338. A "gene" is the "fundamental physical and functional unit
of heredity." Glossary, supra note 6, at 379.
20 Marne E. Brom, Note, Insurers and Genetic Testing: Shopping for that
Perfect Pair of Genes, 40 DRAKE L. REv. 121, 123 (1990/1991) (citing JAMES
J. NORA & F. CLARKE FRASER, MEDICAL GENETICS: PRINCIPLES AND PRACTICE
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is composed of four bases that are paired.2 Human chromosomes
range in size from 50 million to 250 million of these base pairs.2
The four bases form the "alphabet of the genetic code," and
variations in the linear ordering of the bases make up different
genetic sequences. 23 Certain segments of these sequences are
genes,2' and it is estimated that up to 100,000 genes exist per
9 (1989)). Deoxyribonucleic acid ("DNA") is "[t]he type of nucleic acid ...
considered to be the autoreproducing component of chromosomes and of many
viruses, and the repository of hereditary characteristics." MEDICAL DICTIONARY,
supra note 7, at 459.
Although the significance of DNA cannot be overstated in the context of
genetic testing and disease predictability, DNA is also becoming extremely
important in criminal proceedings. For example, the Florida District Court of
Appeals in Andrews v. State, 533 So. 2d 841 (Fla. Dist. Ct. App. 1988),
affirmed a defendant's rape conviction on the basis of DNA tests "resulting in
the first criminal conviction based on DNA evidence in the United States."
Denise A. Filocoma, Comment, Unravelling the DNA Controversy: People v.
Wesley, A Step in the Right Direction, 3 J.L. & POL'Y 537, 542 (1995).
Currently, state courts are "grappling" with the issues of DNA reliability and
admissibility. See, e.g., James Morgan, DNA Profiling in North Carolina, 21
N.C. CENT. L.J. 300 (1995) (discussing "the reliability and the credence the
North Carolina courts have given DNA analysis"); Scott D. Sherwood, The
Pennsylvania Supreme Court Defines the Standard of Admissibility for DNA
Evidence at Trial-Commonwealth v. Crews, 640 A.2d 395 (Pa. 1994), 68
TEMPLE L. REv. 953 (1995) (discussing the Pennsylvania Supreme Court's
admission of testimony concerning DNA matching); Michael J. Short, Forensic
DNA Analysis: An Examination of Common Objections Raised to the Admission
of DNA Fingerprinting as Illustrated by State v. Pierce, 19 DAYTON L. REV. 133
(1993) (discussing the admissibility of DNA testing in criminal trials); Filocoma,
supra (analyzing the New York Court of Appeals decision which found "DNA
evidence was . . . generally accepted as reliable"); Sarah E. Snyder, Note,
Experimental or Demonstrable: Has DNA Testing Truly Emerged from the
Twilight Zone? An Assessment of Washington's Response to DNA Identification,
31 WILLAMETTE L. REv. 201 (1995) (discussing Washington state's handling of
the introduction of DNA evidence in criminal trials).
21 Daniel J. Kevles, Out of Eugenics: The Historical Politics of the Human
Genome, in THE CODE OF CODES, supra note 6, at 3, 15. The bases are bonded
together in pairs of either adenine and thymine or cytosine and guanine. Kevles,
supra, at 15.
22 Kevles, supra note 21, at 17.
23 Kevles, supra note 21, at 15.
24 Kevles, supra note 21, at 15.
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person." Genes are responsible for the structures and properties
of proteins which make up a large portion of the body. 26 A
mutation in a gene may lead to defects in the corresponding
protein, resulting in a genetic disease.27
More than 5,000 human disorders have a genetic component, 8
and affect over half the population of the United States.29 Certain
disorders can be caused directly by gene defects,3° while others,
25 William H. Alexander, Overview of Genetics, in THE POTENTIAL ROLE OF
GENETIC TESTING IN RISK CLASSIFICATION 31, 33 (Genetic Testing Committee
to the Medical Section of the American Council of Life Insurance ed., 1989)
(noting that 100,000 genes make up only six percent of the total chromosomal
DNA while the rest is repetitive, involved in regulatory function or has no
known function). Only 8,000 human genes have been identified to date. James
Schultz, Average Americans Will Gain from Gene Study, Expert Says;
Researchers Believe Cures Are Embedded in Genetics, VIRGINIAN-PILOT, Oct. 11,
1995, at B 1. However, identification has rapidly accelerated since the late 1980s,
and today, four to five new genes are discovered each week. Id.
26 Sue Goetinck, A New Body of Knowledge; Gene Project Unravels
Mysteries, Changes Future Course of Biology, DALLAS MORNING NEWS, Oct. 15,
1995, at 1J. Proteins make up skin, hair and organs. Other proteins "integrate the
different parts of the body, process information in the brain, send and receive
hormone signals, and activate other genes." Id.
27 Brom, supra note 20, at 123.
28 Steve Gushee, Tempest in a Test Tube, PALM BEACH POST, May 29, 1995,
at 1 D (noting that 150 new genetic diseases are discovered each year). More than
15 million Americans suffer from inherited diseases which also account for
one-third of all childhood hospitalizations, and almost half of all infant deaths.
Chris Petrakos, Theory of Relativity; A Family Medical Tree Can Get to the Root
of Health Concerns, CHI. TRIB., Sept. 25, 1995, at 1 (according to statistics of
the Hereditary Disease Foundation in Santa Monica, California).
29 Alexander, supra note 25, at 31. More than 125 million Americans are
affected by a human disorder with a genetic component. Henry T. Greely, Health
Insurance, Employment Discrimination, and the Genetics Revolution, in THE
CODE OF CODES, supra note 6, at 264, 265.
30 An example of a disease caused directly by a gene defect is cystic fibrosis.
Alexander, supra note 25, at 31. Cystic fibrosis "is the most common simple
genetic disease, occurring once in every 2,300 births." Daniel Green, Testing
Ground for Gene Therapy-Cystic Fibrosis Is Heavily Researched but Progress
Has Been Faltering, FIN. TIMES, Feb. 27, 1996, at 12. The cystic fibrosis gene
is responsible for a protein which regulates the movement of salt across body
membranes. Id.
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like heart disease and some cancers, may result from a genetic
predisposition.31 Genetic disorders can be classified into three
categories: large chromosomal abnormalities," single gene
molecular mutations33 and multi-factorial disorders.34 While some
individuals may not suffer from genetic disease, they may carry an
aberrant gene which can pass to their offspring.35
Genetic disorders are discoverable through genetic testing.36
The availability of genetic testing is increasing as a result of recent
[T]he movement of salt in solution across the surface of the lung is
slowed. That leaves the mucus that coats the lung much stickier than
in healthy people. It becomes both an obstacle for breathing and a
hospitable place for bacteria to multiply. Most cystic fibrosis sufferers
die from lung disease before the age of 30.
Id.
3" Alexander, supra note 25, at 31. An individual has the propensity to
develop a genetic disorder when environmental factors "[tip] the balance of the
genetically primed individual towards disease." Alexander, supra note 25, at 35.
32 Chromosomal abnormalities result from changes in the structure or
number of chromosomes. OFFICE OF TECHNOLOGY ASSESSMENT, MAPPING OUR
GENES; GENOME PROJECTS: How BIG, How FAST? 25-26 (1988) [hereinafter
MAPPING OUR GENES]. An example is Down's syndrome which results from
three copies of chromosome 21 instead of the normal two. Alexander, supra note
25, at 31.
" Molecular mutations result from changes in the sequence or number of
bases that make up DNA. MAPPING OUR GENES, supra note 32, at 25. An
example of a disease caused by molecular mutations is sickle cell anemia.
Alexander, supra note 25, at 31. Sickle cell anemia results from a substitution
in the DNA of an adenine by a thymine. ELIAS & ANNAS, supra note 9, at 101.
The disease is characterized by crescent-shaped red blood cells. MEDICAL
DICTIONARY, supra note 7, at 78.
" A disorder is multi-factorial when its expression depends both on one or
more pairs of genes, each having a small additive effect, and factors in the
environment. Alexander, supra note 25, at 35. The bulk of adult diseases are
multi-factorial, and "display variable patterns of inheritance." Alexander, supra
note 25, at 31. Examples are diabetes mellitus, heart disease and mental
disorders, such as manic depression. Alexander, supra note 25, at 31.
" Alexander, supra note 25, at 31-32. "The thousands of genes that we
inherit from our parents at the moment of conception not only determine our
physical characteristics, such as the color of our hair and eyes, but they exert a
strong influence over our health." Petrakos, supra note 28, at 1.
36 Natowicz, supra note 5, at 465.
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advances in genetics that have improved the understanding and
diagnosis of many disorders.37 Currently, hundreds of tests that
identify an individual's genetic predisposition to rare inherited
disorders are available.38 Moreover, many tests will soon predict
37 Natowicz, supra note 5, at 465. For example, scientists recently discovered
a protein (HAPI) that may interact with the defective protein of a mutated
Huntington's disease gene, causing a "cascade of events that kill cells in
Huntington patients' brains." Sandra Blakeslee, Newfound Brain Protein May Be
'Smoking Gun' in Huntington's Disease, N.Y. TIMES, Nov. 14, 1995, at C3. See
Sandra Blakeslee, Protein Culprit Acts to Cause Huntington's, N.Y. TIMES, Mar.
5, 1996, at C8 (discussing "new insight into the underlying mechanisms in
Huntington's disease"). Huntington's is a rare disease which affects one person
in 10,000. Richard Saltus, Genetic Clairvoyance, BOSTON GLOBE, Jan. 8, 1995,
(Magazine), at 14, 26. "About 150,000 relatives of [Huntington's disease]
patients in the United States are at risk." Id. Huntington's disease usually does
not manifest until the thirties, forties, or later, and is known as an "adult-onset"
disorder. Id. at 32. An afflicted person loses body movement control as "vital
parts of the brain atrophy." Personality changes and depression are also common.
Id. After 15 to 20 years, the "disability and dementia worsen" and much of the
patient's memory and speech is destroyed. Death often results from infection. Id.
See generally Simeon Margolis, Diagnosing, Predicting Huntington's Disease,
BALTIMORE SuN, Dec. 19, 1995, at 5E.
In addition, researchers have discovered a gene which causes malignant
melanoma, an aggressive form of skin cancer, Lawrence Fisher, Second Gene is
Linked to a Deadly Skin Cancer, N.Y. TIMES, Jan. 2, 1996, at B18, and a gene
linked to pancreatic cancer. Gene Discovery; Another Gene Linked to Pancreatic
Cancer, Feb. 12, 1996, available in LEXIS, Nexis Library, CURNWS File.
Scientists also claim there may even be possible genetic links with homosexuali-
ty, shyness, grammar, aggression and alcoholism. Joe Donnelly, Joe Donnelly
Reports on the Benefits of a Genetic Breakthrough and Warns of the Ethical
Dangers, HERALD (GLASGOW), Oct. 19, 1995, at 16; see also Nigel Hawkes,
Bad-tempered and Extravagant? Blame it on the Genes, Jan. 2, 1996, available
in LEXIS, Nexis Library, CURNWS File (discussing a gene independently
identified by two groups of scientists "that makes some people extrovert[ed] and
eager for new experiences and others stolid and introverted").
" About 500 laboratories in the United States provide some type of genetic
testing. Genetic Screening: An Idea Whose Time is Coming, Slowly, Sept. 1994,
available in LEXIS, Nexis Library, CURNWS File. "The genetic diagnostic
market in the United States currently consists of tests for the prenatal detection
of chromosomal abnormalities, identification of genetic defects in infants, testing
for both the disease and carriers of single-gene defects, and detection of genetic
cancer markers." Id. Genetic tests for the following diseases are now available:
some forms of leukemia, some forms of cancer, cystic fibrosis, fragile X (type
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more common illnesses, such as heart disease.39 Gene discoveries
concerning Alzheimer's disease40 and, more recently, breast
of mental retardation), myotonic dystrophy (progressive muscle weakness,
MEDICAL DICTIONARY, supra note 7, at 537), some forms of ataxia (inability to
coordinate muscle activity, MEDICAL DICTIONARY, supra note 7, at 161),
hemophilia, Huntington's disease, sickle cell anemia and Tay-Sachs disease.
Gordon Slovut, Genetics and Medicine; Genetic Testing Makes an Ounce of
Prediction Worth Pound of Fear; Patients, Insurers, Doctors Question Who
Should Be Told, STAR TRIB., Oct. 25, 1995, at IA. See Heather McClure, The
Insurance Industry's Use of Genetic Information: Legal and Ethical Concerns,
28 J. HEALTH & Hosp. L. 231, 232-33 (1995) (listing genetic tests available and
their costs); see also Genetic Disease is Targeted; Testing Offered for Those at
Risk of Developing Huntington's Disease, MILWAUKEE J. SENTINEL, Oct. 2,
1995, at 5 (highlighting two physicians that offer presymptomatic testing for
people at risk of developing Huntington's disease); New Test to Detect Cancer
Proves Cheaper and More Precise, Feb. 2, 1996, available in LEXIS, Nexis
Library, CURNWS File (discussing a new test to detect bladder cancer which is
"twice as precise and much less expensive than tests currently used"); Denise
Grady, Tracing a Genetic Disease to Bits of Traveling DNA, N.Y. TIMES, Mar.
5, 1996, at C1, C5 (discussing a discovery concerning Charcot-Marie-Tooth
syndrome, a nerve deterioration disorder, that can "lead to simpler diagnostic
tests").
" Seth Shulman, Legislation Aims to Prevent Genetic Discrimination by
Insurers, TIMES UNION, July 16, 1995, at E2. Genetic tests will soon be available
for the following diseases: heart disease, prostate, colon, melanoma and lung
cancers, autoimmune diseases, diabetes and Alzheimer's disease. Slovut, supra
note 38, at IA. See Ulysses Torassa, Family Ties, PLAIN DEALER, Dec. 17, 1995,
at 5 (discussing the process of one scientist's discovery of a colon cancer gene);
see also Michael Lasalandra, Hub Researchers Help ID Alzheimer's Gene,
BOSTON HERALD, Aug. 18, 1995, at 5; Paul Recer, Gene Discovery May Be a
Key to Puzzles of Cancer, SAN DIEGO UNION & TRIB., June 23, 1995, at Al;
Discovery of Breast Cancer Gene Opens New Research Door, CHI. TRIB., Feb.
15, 1995, at 7.
40 See Gina Kolata, If Tests Hint Alzheimer's, Should a Patient Be Told?,
N.Y. TIMES, Oct. 24, 1995, at Al, C6. Researchers have confirmed a link
between Alzheimer's disease and the apoE gene. Id. at C6. There are four
variations of the apoE gene (El, E2, E3 and E4), and according to studies,
individuals who inherit two copies of apoE4 have approximately six times the
normal risk of developing the disease. Id. Inheriting only one copy of apoE4
confers a threefold increased risk. Id. In contrast, inheriting two copies of apoE2
may protect a person from developing Alzheimer's. Id. "From half to two-thirds
of all Alzheimer's patients have at least one copy of an apoE4 gene. But just
15[%] of the general population has an E4 gene." Id.
560
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cancer4 now elucidate the causes of these diseases. Thus, the
" See Gina Kolata, Breast Cancer Gene in 1% of US. Jews, N.Y. TIMES,
Sept. 29, 1995, atA24. Biologists have discovered that a particular genetic defect
in the gene BRCAI, which was found to be associated with familial breast
cancer, is found with unusual frequency in American Ashkenazi Jews (whose
ancestors lived in Eastern and Central Europe). Id. The mutation is a small
deletion of genetic material which causes a defective protein, destroying the
gene's function of suppressing malignant changes. Id. Women with both a
BRCAI mutation and a family history of breast cancer are at a considerably
increased risk to develop breast cancer. Id. "[T]he mutation confers an 80[%] to
90[%] chance of getting breast cancer and a 40[%] to 50[%] chance of
developing ovarian cancer. There are also hints that it might lead to colon cancer
and, in men, prostate cancer." Id. As many as 1% of Ashkenazi Jews have this
mutation, which in effect amounts to 1% of all American Jews since 90% to
95% are of Ashkenazi descent. Id. It is estimated that the mutation could account
for as much as 16% of the breast cancer and 39% of the ovarian cancer in Jewish
women under age 50. Robert Cooke & Earl Lane, Cancer-Enhancing Mutation
Found in Certain Jews; Genetic Aberration in Eastern European Women Could
Bring Widespread Screening, AUSTIN AM. STATESMAN, Sept. 29, 1995, at A4.
Only one in 800 non-Jews are expected to have this genetic defect. Kolata, supra,
at A24. According to Dr. Francis S. Collins, director of the National Center for
Human Genome Research in Bethesda, Maryland, this mutation is the most
common genetic disorder for the Jewish population. Kolata, supra, at A24; see
also Richard Saltus, Gene in Some Jewish Women Tied to Cancer Risk, BOSTON
GLOBE, Sept. 29, 1995, at 1 (describing the genetic mutation and its impli-
cations).
Furthermore, researchers have recently discovered that women with breast
cancer who do not have a family history of the disease have certain abnormalities
related to the BRCA1 gene. Gina Kolata, Research Links Single Gene to Almost
All Breast Cancers, N.Y. TIMES, Nov. 3, 1995, at Al, D19. In addition, new
studies have shown that the BRCA 1 gene is often the cause of breast cancer in
women in their twenties and thirties, even when there is no familial history.
Breast Cancer in Young Tied to Faulty Gene, N.Y. TIMES, Jan. 18, 1996, at A 19.
According to Dr. Richard Klausner, director of the National Cancer Institute,
"[i]t takes genetic susceptibility the next step--from individuals who are
members of pre-selected families with a history of cancer-and now looks at all
young women." Id. at A19. Therefore, the BRCA1 gene plays even more of a
pivotal role in breast cancer than previously suspected. Kolata, supra, at D1 9. See
Natalie Angier, Surprising Role Found for Breast Cancer Gene, N.Y. TIMES,
Mar. 5, 1996, Cl, C3 (discussing the discovery of essential properties of the
BRCA1 gene that could lead to new treatments). Moreover, on December 21,
1995, another breast cancer gene, BRCA2, was disclosed. Gina Kolata, Scientists
Speedily Locate a Gene that Causes Breast Cancer; Better Screening Is Seen,
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medical community must immediately confront ethical issues,4 2
such as whether to deliver genetic services to the general popu-
lation, because researchers are ready to execute genetic
screenings.43
N.Y. TIMES, Dec. 21, 1995, at B 18. Mutations in this gene may "account for an
additional third of hereditary breast cancer and possibly all of it that is not
caused by BRCA 1 mutations." Id.
42 According to one commentator, "[a] technology-driven culture says let's
introduce the technology first and the ethics questions second." John A. Nagy,
Scientists Dig for Diseases 'Roots, GREENSBORO NEWS & REC., Nov. 13, 1995,
at Al (quoting Nancy King, a specialist in medical ethics at the University of
North Carolina-Chapel Hill). Doctors face ethical issues of confidentiality and
disclosure if patients with genetic diseases refuse to share the information with
family members. Marilyn Moysa, Disclosure of 'Bad Genes' Urged in Study;
MD-Patient Confidentiality at Issue, EDMONTON J., Dec. 23, 1995, at A3. In
addition, doctors may diagnose genetic disorders, but may not be able to offer
cures or preventive measures. See Laurie Smith Anderson, Scientists Explore
Implications of New KnowledgeAbout Genes, ADVOCATE, Feb. 15, 1996, at 18A;
Fletcher Stack, Ethics: Lines Graying in Medicine, SALT LAKE TRIB., Dec. 25,
1994, at AI. Other ethical issues involving widespread genetic testing include
"labeling and discrimination," and the fact that people will "give too much
weight to the genetic component of behavior and neglect social elements." Stack,
supra, at Al. The ultimate ethics questions deal with "breeding a 'superior'
human being based on the parents' desirable genetic traits," and sterilizing or
even killing "people with 'undesirable' traits." Stack, supra, at Al; see also
Sandra Blakeslee, Advances in Genetics Give Biology Curriculums a Thought-
Provoking New Dimension, N.Y. TIMES, Mar. 6, 1996, at B9 (discussing a new
biology curriculum that contains exercises exploring the "ethical questions raised
by [genetic] research"); John F. Haught, Ethical Views of Humans and Genetic
Engineering, WASH. TIMES, Mar. 31, 1996, at B8 (commenting on the ethical
issues raised by Philip Kitcher's recent book THE LIVES TO COME: THE GENETIC
REVOLUTION AND HUMAN POSSIBILITIES (1996)).
" General population screenings can now be achieved. For instance,
biologists have discovered a genetic defect in the gene BRCA1 which causes
breast cancer, and the defect is the most common genetic disorder for the Jewish
population. Kolata, supra note 41, at A24. Because there are six million
Ashkenazi Jews in the United States, testing would be easy because it involves
looking for a single gene alteration at a known position. Kolata, supra note 41,
at A24. Thus, as of September 1995, large scale genetic screening can be easily
done to test millions of healthy people for breast cancer. See Cancer Gene
Analysis AnnouncedAvailable to High Risk Patients, Jan. 22, 1996, available in
LEXIS, Nexis Library, CURNWS File (discussing a Maryland company's
offering of BRCA 1 genetic testing "to any person in the United States who is
562
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II. DISCRIMINATION BY INSURERS USING GENETIC TESTING
A large majority of the United States population is covered
through a variety of health care mechanisms," which include
private group insurance, individually purchased insurance, Medicare
and Medicaid.45 Individually purchased health insurance is based
on medical underwriting,46 which takes an individual's health
considered to be at high risk for inherited breast-ovarian cancer ... "); Gina
Kolata, Breaking Ranks, Lab Offers Test to Assess Risk of Breast Cancer, N.Y.
TIMES, Apr. 1, 1996, at Al (discussing a Virginia company's decision to offer
BRCA1 genetic tests to the general public). Moreover, recent mutations found
in the BRCA2 gene may "account for an additional third of hereditary breast
cancer and possibly all of it that is not caused by BRCA1 mutations." Kolata,
supra note 41, at B18. As a result of this discovery, scientists "will be able to
offer greatly improved genetic screening to women in so-called breast cancer
families." Kolata, supra note 41, at B18. For a discussion of the negative social
and psychological consequences of widespread genetic screening, see Angus
Clarke, Populations Screeningfor Genetic Susceptibility to Disease, 310 BRITISH
MED. J. 35 (1995); see also Catherine Clabby, Scientist Discovers 2nd Breast
Cancer Gene; Duke Researcher's Concern About Bias in Insurance Mutes
Medical Triumph, NEWS & OBSERVER, Dec. 21, 1995, at Al (discussing the
offering of BRCA1 and BRCA2 genetic tests at Duke University, and the
negative implications of such tests); Warren E. Leary, Doctors' Group
Recommends Reducing Cholesterol Checks, N.Y. TIMES, Mar. 1, 1996, at A 18
(discussing guidelines which recommend restricting routine cholesterol testing to
35 to 65-year-old men and 45 to 65-year-old-women).
" Approximately 84% of the United States population, or 210 million
people, was covered by health insurance in 1994, Pulse; Uninsured, N.Y. TIMES,
Oct. 28, 1995, at 23, while approximately 40 million people were uninsured.
Kathy L. Hudson et al., Genetic Discrimination and Health Insurance: An Urgent
Need For Reform, 270 SCIENCE 391, 391 (1995).
4' Greely, supra note 29, at 265. Ten to fifteen million people rely on
individually purchased health insurance while approximately 150 million have
private group insurance, usually as an employee, employee's spouse or
dependent. Greely, supra note 29, at 265. In addition, approximately 55 million
Americans rely on public insurance like Medicare and Medicaid. Greely, supra
note 29, at 265.
46 Greely, supra note 29, at 265. "Medical underwriting" is the process used
by an insurance company to evaluate different risk factors including age, gender,
health history, general physical condition, occupation, alcohol or tobacco use,
family history and serum cholesterol, in order to determine an applicant's
JOURNAL OF LAW AND POLICY
status into account when an application for insurance is
reviewed. 47 Therefore, improvements in predicting a person's
contribution to the common "pool" of all policy holders. Robert J. Pokorski,
Principles of Insurance and Risk Classification, in THE POTENTIAL ROLE OF
GENETIC TESTING IN RISK CLASSIFICATION, supra note 25, at 45, 45. "The
higher the risk, the higher the premium; the lower the risk, the lower the
premium." Pokorski, supra, at 45. The goal of underwriting is to treat
policyholders with "similar expected risk of loss" the same. Pokorski, supra, at
45. Insurance rates and premiums are computed on the basis of actuarial tables
consisting of statistical data which indicates life expectancy and mortality.
BLACK'S LAW DICTIONARY 36 (6th ed. 1990).
A current debate exists over whether insurers should be allowed to use an
individual's genetic information for underwriting. Insurers argue that if genetic
information is available, "they have an undisputed right to it." Damian Reece, A
Premium on Your Genes; Insurers Want Access to Genetic Test Results but a
Row is Brewing Over the Ethics of Their Demands, SUN. TELEGRAPH, Feb. 11,
1996, at 10. They claim that by withholding the information "the principle of life
assurance would collapse." Id; see also Roberta B. Meyer, Justification for
Permitting Life Insurers to Continue to Underwrite on the Basis of Genetic
Information and Genetic Test Results, 27 SUFFOLK U. L. REV. 1271 (maintaing
that life insurers should be allowed to use genetic information in underwriting).
See notes and accompanying text infra part III (discussing the weaknesses of
using genetic testing to underwrite), and notes and accompanying text infra p.
608 (comparing health and life insurance).
" Greely, supra note 29, at 265. Individuals participating in a public
insurance plan, such as Medicare, Medicaid and Social Security, are
automatically insured, including those deemed poor risks and those with terminal
illnesses. Robert J. Pokorski, Public and Government Relations Issues, in THE
POTENTIAL ROLE OF GENETIC TESTING IN RISK CLASSIFICATION, supra note 25,
at 9, 11. Additionally, in private group health insurance, insurers consider
relevant characteristics of the group, and not characteristics of each individual
member. T.H. Cushing, Should There Be Genetic Testing in Insurance Risk
Classification?, 60 DEF. COUNS. J. 249, 257 (1993). In fact, evidence of the
insurability of each individual is usually not required. Id. However, an employer
may discriminate and reject an applicant based on genetic information due to the
possibility ofincreasedmedical and insurance premiums. Kimberly Nobles, Note,
Birthright or Life Sentence: Controlling the Threat of Genetic Testing, 65 S.
CAL. L. REv. 2081, 2089 (1992). See generally Mark Rothstein, Discrimination
Based on Genetic Information, 33 JURIMETRICS J. 13 (1992) (illustrating the use
of genetic information by employers); see also discussion of the Americans with
Disabilities Act ("ADA") infra pp. 581-82 (discussing recent Equal Employment
Opportunity Commission guidelines that extend coverage of the ADA to
individuals regarded as having genetic impairments).
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health will greatly affect individually purchased insurance,48 and
unfortunately also lead to discrimination based on genetic
information.
Insurance companies have used the results of genetic tests "to
justify canceling coverage, saying that a genetic abnormality is a
preexisting condition; to deny coverage to unaffected relatives of
a person with a genetic disorder; and to refuse to issue a policy
unless an applicant submits to a genetic test."49 In one study,
researchers found that one hundred people were denied insurance
benefits because of genetic risks.50 According to one commentator,
twenty-two percent of families that were diagnosed with a genetic
flaw have been denied health insurance,5 while a survey of
families with inherited diseases found that thirty-one percent were
denied coverage although there was no actual illness.52
Individuals at risk for genetic discrimination include those who
carry a gene for a disease that may develop, but are currently
asymptomatic." One example of this involved an eight-year-old
girl who was diagnosed as having phenylketonuria ("PKU")54
when she was fourteen-days-old." At that time a low
phenylalanine diet was instituted.56 According to her clinical geneticist, 57
4 Greely, supra note 29, at 265.
'9 Ince, supra note 5, at 4.
50 Richard Liefer, Congress Told to Protect Privacy of Americans Who Get
Gene Tests, CHI. TRIB., Sept. 30, 1995, at 10.
"' Genetic Knowledge Brings Ethical Dilemmas, MILWAUKEE J. SENTINEL,
Oct. 6, 1995, at 2.
5 Liefer, supra note 50, at 10. Many people ask their health care providers
if they can pay for genetic tests in cash in order to keep the results from their
insurance companies. Paul Cotton, Prognosis, Diagnosis, or Who Knows? Time
to Learn What Gene Tests Mean, 273 JAMA 93, 93 (1995).
5 Natowicz, supra note 5, at 466.
5 Phenylketonuria ("PKU") is an inherited disease in which the amino acid
phenylalanine cannot be metabolized. If special diets are not instituted, mental
retardation, seizures and psychotic disorders will develop. Laurie Smith
Anderson, Should Newborns Undergo Routine Genetic Tests as They Become
Available?, BATON ROUGE ADVOC., Nov. 4, 1994, at IC, S.
5 Billings, supra note 5, at 478.
56 Billings, supra note 5, at 478.
" A "clinical geneticist" is "[a]n individual who holds an M.D., D.D.S.,
D.M.D., or D.O. degree and can demonstrate competence to provide
565
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[g]rowth and development have been completely normal.
... Routine developmental assessments done at 26 weeks,
53 weeks, and 54 months revealed skills solidly appropriate
for age, and in many instances skills were above age
expected levels. The child continues to be developmentally
normal and be healthy. The circumstances of the discrimi-
nation that this child has experienced involve rejection for
medical insurance. . . . [W]hen [her father] changed jobs
recently, he was told that his daughter was considered to
be a high risk patient because of her diagnosis, and
therefore ineligible for insurance coverage under their
group plan. She is currently being covered at the expense
of her family, but this is a temporary solution at best.
58
Thus, insurers will deny insurance based on genetic information
even though an individual may never manifest the genetic disorder.
Another group of individuals at risk for genetic discrimination
includes relatives of people with known or presumed genetic
characteristics. 59 An example is discrimination against a person
with a familial history of Huntington's disease, a rare disease which
affects one person in 10,000.60 "About 150,000 relatives of
[Huntington's disease] patients in the United States are at risk."6'
For instance, "[i]n Boston, a woman with a family history of
Huntington's made [thirteen] unsuccessful applications for health
insurance before the test showed she hadn't inherited the gene ...
'She couldn't even get insurance for her children.' "62
Genetic discrimination also occurs with otherwise healthy
individuals. One example of this discrimination involved a man
comprehensive diagnostic, management, and counseling services." ELIAS &
ANNAS, supra note 9, at 36. See generally Kathy Katella, Connecticut Q&A:
Ellen Matloff; The Secrets of Your Genes and What to Do, N.Y. TIMES, Mar. 24,
1996, at 3 (containing excerpts from a conversation about genetic testing with
genetic counselor Ellen Matloff); A.B. 7840, 219th Gen. Assembly, 1995-96 Reg.
Sess. (N.Y. 1995) (proposing regulations on the licensure of genetic counselors).
58 Billings, supra note 5, at 478.
'9 Natowicz, supra note 5, at 466.
60 Saltus, supra note 37, at 26.
61 Saltus, supra note 37, at 26.




who suffered a heart attack.63 His insurer "refused to pay the
hospital bills or cover future treatment for cardiovascular disease"
after a genetic test revealed he had a hereditary type of high
cholesterol. 64 The insurer argued that since he had the "faulty
gene" at birth, it "counted as a preexisting condition. '65 Such
63 Ince, supra note 5, at 3-4.
64 Ince, supra note 5, at 4.
65 Ince, supra note 5, at 4. A "preexisting condition" is a "condition which
either existed at the inception of the [insurance] contract or that occurs during
a prescribed period after the insurance goes into effect." Alan I. Widiss, To
Insure or Not to Insure Persons Infected with the Virus that Causes AIDS, 77
IOWA L. REV. 1617, 1714 (1992). Preexisting condition clauses exclude, restrict
or postpone insurance coverage. Id. In general, insurers refuse to issue insurance
to individuals when the risk of developing the disease is too great. Pokorski,
supra note 46, at 46.
There is a point where yearly premiums for certain risks become so
high that they appear to be unaffordable to most people. At this point,
only a very small percent of those who are offered such insurance will
accept. And these tend to be people who know more about their health
problems than the underwriter was able to learn. So even if the
premium were set quite high, it would probably be inadequate to cover
claims.
Pokorski, supra note 46, at 46.
On July 13, 1995, Senators Nancy Kassebaum (R-KS) and Edward Kennedy
(D-MA) introduced the Health Insurance Reform Act of 1995, which would
prohibit insurers from denying individuals insurance coverage based on
preexisting conditions. S. 1028, 104th Cong., 1st Sess. (1995). President Bill
Clinton endorsed the bill during his State of the Union Address on January 23,
1996. Christina Kent, Bipartisan Push for Insurance Reform Bill, AM. MED.
NEWS, Feb. 12, 1996, at 3. See Helen Dewar, Key GOP Senators Agree to
Consider Limited Health Insurance Bill in Spring, WASH. POST, Feb. 7, 1996,
at A5 (discussing the legislation). Representative Marge Roukema (R-NJ)
introduced an almost identical bill in the House of Representatives on January
25, 1996. H.R. 2893, 104th Cong., 2d Sess. (1996). However, Representative
Dennis Hastert (R-IL), leader of the House Republican task force on health care
reform, advocates a different "multi-pronged approach aimed at providing
affordable coverage. . . ." Bob Estill, Democrats Alter Diagnosis of Republican
Health Plan, STATE J. REGISTER, Mar. 15, 1996, at 9. Representative Bill Archer
(R-TX) utilized this approach when he introduced the Health Coverage
Availability Act of 1996 on March 18, 1996. H.R. 3103, 104th Cong., 2d Sess.
(1996). The bill was amended by H.R. Res. 392, 104th Cong., 2d Sess. (1996),
which substituted and combined H.R. 3103 with H.R. 3160, 104th Cong., 2d
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actions by insurance companies have negative implications for
many healthy and insured individuals. Once a gene is linked with
a particular disease, sufferers of the disease could lose their
insurance and security because of an unknown "preexisting
condition."66 The threat of genetic discrimination is real, and
"millions of Americans risk losing health coverage because they
carry genes making them vulnerable to disease.
67
III. WEAKNESSES OF USING GENETIC TESTING FOR
INSURABILITY
Insurers currently use family history in medical underwriting,
which acts as a surrogate for genetic information. 68 According to
Sess. (1996). The House passed this substituted version on March 28, 1996, with
all Republicans except Marge Roukema voting for the bill. Robert Pear, House
Approves a Bill to Broaden Health Insurance, N.Y. TIMES, Mar. 29, 1996, at A 1.
See notes and accompanying text infra pp. 585-87 (discussing the genetic
information provisions of H.R. 3103/3160). In response to the Republican
approach, House Minority Leader Richard Gephardt (D-MO) stated that:
the Republicans want to turn a straightforward health insurance reform
bill into a special interest smorgasbord. According to Congressman
Dennis Hastert, they plan to load up the bill with controversial,
divisive provisions that would doom its chance of becoming law. At
the same time, it is still unclear whether their bill would even contain
the insurance reforms people need and demand.
Statement by House Democratic Leader RichardA. Gephardt on Republican Plan
to Load Up Health Insurance Reform Bill with Controversial Provisions, PR
Newswire, Mar. 8, 1996, available in LEXIS, Nexis Library, WIRES File.
66 "[E]very single person has between 10 and 20 genes that are abnormal or
mutated." Katella, supra note 57, at 3. In addition, "[s]cientists believe that each
person carries five genes that are capable of causing disease or disability or even
death." The Age of Genes, INDIANAPOLIS STAR, Oct. 23, 1995, at A6. For
instance, one person out of every 20 carries the recessive gene for cystic fibrosis.
Paul Daugherty, Esiason Finds Life Lacks Warnings; Son of Jets Quarterback
Diagnosed with Cystic Fibrosis, SAN FRAN. EXAMINER, June 27, 1993, at C2. A
child may suffer from cystic fibrosis if both parents are carriers. Id.
67 Medical Ethics: Experts Recommend Genetic Privacy Laws, AM. HEALTH
LINE, Oct. 23, 1995, at 12 (citing top U.S. health officials who appealed to
insurance companies to end "discriminatory insurance practices").
68 A Little Knowledge, ECONOMIST, Feb. 25, 1995, at 13, 15. The purpose
of using familial history is to achieve actuarial fairness. Id "If people can be
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a 1992 survey by the United States Office of Technology Assess-
ment, a majority of insurers believe that it is fair for them to have
access to genetic test results for medical underwriting.69 Although
insurers regard genetic testing as "an extension of diagnostic tests
that describe people's current condition,"7 they should acknowl-
edge the difference between tests that reveal existing health
problems, and those that only predict disease susceptibility.7'
Moreover, genetic tests do not predict an illness' severity or the age
of onset.
72
Another problem with relying on genetic tests for medical
underwriting is that reliance on genetic tests may cause insurers to
overlook environmental factors that affect a person's health.73 As
one commentator pointed out, "in our excitement we forget that
there's still the nurture part of the equation. It hasn't gone away
just because we have the opportunity to understand the nature part
sorted into different classes of risk, those in the lower risk categories should pay
lower premiums for the same cover." Id. Knowing an individual's genetic
information from testing could make medical insurance actuarially fairer because
people with unknown predispositions are currently treated the same as other
applicants. Id. However, "[i]t might be actuarially unfair on the utterly healthy;
but one of the implications of genetic testing is that no one is utterly healthy. At
some level, there is something in everyone's genome that could get them into
trouble eventually." Id.
69 ASSESSING GENETIC RISKS, supra note 2, at 269-70.
70 Genetic Testing; Protecting the Rights of the Insured, STAR TRIB., Feb.
14, 1995, at 12A [hereinafter Protecting the Rights of the Insured].
71 Id The accuracy of a particular genetic test in predicting susceptibility
depends on the disease. Id. For most illnesses, the accuracy is less than 100%.
Id. Genetic tests for illness, such as a predisposition for cancer, only yield a
probability and not a specific prediction because some people who carry the gene
may not develop the disease. Saltus, supra note 37, at 33-34.
72 Protecting the Rights of the Insured, supra note 70, at 12A. For example,
although the genetic test for the gene that causes Huntington's disease is
completely accurate, a positive result does not predict when the disease will
appear. Saltus, supra note 37, at 33. Thus, an individual may be denied insurance
based on genetic information while completely healthy. See Susan O'Hara,
Comment, The Use of Genetic Testing in the Health Insurance Industry: The
Creation of a "Biologic Underclass," 22 SW. U. L. REv. 1211 (1993)
(explaining the limited powers of genetic testing in predicting disease).
73 Protecting the Rights of the Insured, supra note 70, at 12A.
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more quantitatively. ' 74 For instance, one study suggests that a
woman's environment or diet may influence her risk of breast
cancer.7 Likewise, studies on the risk factors associated with
prostate cancer have implicated a diet high in animal fat.76
Furthermore, while some gene variations77 may increase the
chance of developing cancer,78 these variations "raise the specter
" Charles Siebert, The DNA We've Been Dealt, N.Y. TIMEs, Sept. 17, 1995,
§ 6 (Magazine), at 50, 94 (quoting Dr. Francis Collins, director of the National
Center for Human Genome Research). See Jane E. Brody, Good Habits Outweigh
Genes as Key to a Healthy Old Age, N.Y. TiMES, Feb. 28, 1996, at C9
(discussing studies that show people can successfully "foster a healthy and
productive old age" by remaining physically and socially active).
" New Study Suggests a Woman's Breast Cancer Risk May Be Influenced
by Environment or Diet Instead of Just Genetics (CBS Evening News, Aug. 2,
1995) (available in WESTLAW, CBSEVNEWS database). The study found that
women who move to a new country eventually have the same breast cancer risk
as native-born women, suggesting that the risk of breast cancer does not
completely depend on genetic makeup. Id
A recent controversy in Long Island, New York, over the causes of a high
incidence of breast cancer resulted in study mandated by Congress. Ford
Fessenden, Meeting of Minds on Cancer Study, NEWSDAY, Mar. 15, 1995, at
A27. The Long Island Breast Cancer Study Project will conduct a four-year
study that "will focus on environmental causes of breast cancer." Id Breast
cancer activists claim that "something endemic to Long Island-water contami-
nation, pesticide use, landfills near homes-may be causing higher levels of
breast cancer." Michelle Slatalla, Cancer Cluster? A Look at 1 Neighborhood
That Seemed to Be a Classic Example, NEWSDAY, Dec. 5, 1993, at 4.
76 Dean Edell, Gene Testing Could Result in Discrimination: Study,
HousToN POST, Aug. 28, 1994, at EIO (finding that there is a lower rate of
prostate cancer death in countries like Japan, Singapore and Greece, where
people eat little animal fat, than in the United States, where animal fat from meat
and dairy products are consumed in larger quantities). According to a report
released by a panel of the National Research Council of the National Academy
of Sciences, "Americans trying to avoid cancer-causing substances in foods
would benefit most from eating fewer calories and fats and more fruits and
vegetables." Jane Brody, Chemicals in Food? A Panel of Experts Finds Little
Danger, N.Y. TIMEs, Feb. 16, 1996, at Al, A20.
7" Gene variations are called "polymorphisms." Kathleen Fackelmann,
Variations on a Theme: Interplay of Genes and Environment Elevates Cancer
Risk, SCIENCE NEWS, May 6, 1995, at 280, 280. See supra note 9 (defining
polymorphism).
78 For example, smokers with one type of polymorphism run a high risk of
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of cancer only in the presence of specific environmental
hazards., 79 Thus, genetic testing alone does not reveal the affects
of environmental factors on health, and should not be used to
determine insurability.
IV POLICY CONSIDERATIONS - Do WE REALLY WANT TO
KNOW? 0
Despite the issues of accuracy in genetic testing, society must
also address social policy issues raised by the testing."' Should
people be required to take genetic tests? What if those tested do not
want to know their genetic makeup? How much control can
individuals have over another's access to their test results? 2 The
breast cancer, while another variant may increase a person's chance of
developing a deadly brain cancer. Fackelmann, supra note 77, at 280.
79 Fackelmann, supra note 77, at 280.
'0 For information on the ethical, legal and social implications of the Human
Genome Project, see generally the Internet Uniform Resource Locator:
http://www.oml.gov/TechResources/HumanGenome/resource/elsi.html.
8" "In the absence of state legislation, private parties may conduct
across-the-board genetic testing without the constitutional implications faced by
federally funded programs." Nobles, supra note 47, at 2104. Nonetheless, an
individual may find some safeguards under the Equal Protection Clause of the
Fourteenth Amendment and the right to privacy derived from the Due Process
Clause of the Fourteenth Amendment. For a comprehensive essay that explores
constitutional protections for individuals subject to genetic discrimination, see
George P. Smith, II & Thaddeus J. Bums, Genetic Determinism or Genetic
Discrimination?, 11 J. CONTEMP. HEALTH L. & POL'Y 23 (1994).
82 On May 18, 1995, two marines were court-martialed for failing to give
blood and saliva samples to the Department of Defense for a registry maintained
by the Armed Forces Institute of Pathology in Gaithersburg, Maryland. Arthur
Caplan, The Military and DNA, TIMES UNION, Dec. 12, 1995, at A18. The
military has collected and stored samples from active duty and reserve troops
since June 1992. It intends to use biological records to identify bodily remains
too damaged for dental record or fingerprint identification. Id. The two marines
fear that employers and insurers could discover and use their genetic information
to deny them jobs or insurance. Id. Their fears are justified because "Congress
or the president could order that the specimens in the DNA bank be made
available to the FBI, the CIA, health insurance companies, private businesses,
local police departments or the Medicaid program." Id.
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answers to these questions coupled with the implementation and use
of genetic tests and genetic test results greatly impact the areas of
privacy and autonomy.
Autonomy, in the context of genetic testing and screening,
"refers to the right of persons to make an informed, independent
judgment about whether they wish to be tested and then whether
they wish to know the details of the outcome of the testing." 3
Once a person takes a genetic test, "privacy includes the right to
make an informed, independent decision about whether-and
which-others may know details of their genome. 84  The
principles of privacy and personal autonomy overlap, reflecting the
importance of a person's ability "to make personal decisions
without interference. 85
The marines filed suit in the U.S. District Court of Hawaii, but Judge
Samuel King dismissed the case in September 1995. Stephen Goode, Marines
Stand Ground Against DNA Testing, WASH. TIMEs, Feb. 19, 1996, at 38. The
case is now before the Ninth U.S. Circuit Court of Appeals. Id. "The case could
go all the way to the Supreme Court should the appeals court deny the Marines
the right to refuse the tests." Id See GIs Concerned About Confidentiality of
DNA Dog Tags (All Things Considered-National Public Radio broadcast, March
8, 1996) (transcript No. 2146-16) (discussing the lawsuit with the two marines);
see also H.R. 2873, 104th Cong., 2d Sess. (1996) (proposing "to limit the
collection and use by the Department of Defense of individual genetic identifying
information for the purpose of identification of remains...").
83 ASSESSING GENETIC RISKS, supra note 2, at 248. In a recent survey to
members of the New York City Chapter of the Alzheimer's Association, 63% of
the respondents said that they would take a genetic test for Alzheimer's disease.
Susan Gilbert, Alzheimer's Group Finds Many Members Want Testfor Risk, N.Y.
TIMES, Dec. 13, 1995, at C13. Of the people who did not want the test, 68% said
that the reason was because there was no treatment or cure. Id. In addition, 54%
did not want to know, and 18% were concerned about job, health insurance and
other discrimination. Id.
14 ASSESSING GENETIC RISKS, supra note 2, at 249. See supra note 6
(defining genome).
85 ASSESSING GENETIC RISKS, supra note 2, at 256. Although genetic tests
are "invaluable for tailoring each patient's treatment to the precise molecular
cause of his or her disease.. . .handled wrongly they could destroy employment
prospects, insurance eligibility and much more besides." Clive Cookson, Leaders




Some individuals do not want to know their genetic makeup.16
The lack of effective treatment, anxiety over the testing itself and
the "inability to 'undo' the knowledge" are some reasons people
refuse to take genetic tests.8 7 For example, one woman who tested
positive for Huntington's disease, indicating that she would suffer
from the disorder, found it difficult to accept that her dreams for
the future would not be fulfilled.88 Therefore, as a result of
testing, the hope that a person will not suffer from genetic disease
is irrevocably lost.
One woman, concerned about her children being afflicted with
hypertrophic cardiomyopathy ("HCM"),"9  decided not to
genetically test them. Her concern over the possibility of affliction
was based on familial history:
Their father died six years ago, at 43, after a heart trans-
plant that didn't take. Their uncle had a transplant five
86 Results of a 1994 Time magazine survey indicated 49% of those surveyed
did not want to know if they carried certain genes that were indicators of disease.
Michael Landau, Use of Genetic Testing by Employers and Insurance Companies,
3 DICK. J. ENVTL. L. & POL'Y 105, 118 n.72 (1994) (citing survey, TIME, Jan.
17, 1994, at 50). See generally Charles Siebert, At the Mercy of Our Genes, N.Y.
TIMEs, Jan. 5, 1996, at A3 (explaining the impact of new technology and
information on the "luxury of not knowing").
87 Testing for Cancer Genes: Do You Want to Know?, HEALTH NEWS, Aug.
1995, at 1, 3 [hereinafter Do You Want to Know?].
88 Profile: Ability to Predict Genetic Future Requires Consideration (NBC
Nightly News, July 6, 1995) (transcript available in WESTLAW, NBCNN
database). According to the woman, "[tihe inevitability that you're not going to
necessarily be able to do everything that you wanted to do, that's really hard.
That was hard to accept. And also giving up, you know, a whole life-long set of
dreams. That was hard. That was really hard." Id.
In fact, the brother of this woman decided not to know his genetic future.
According to the brother, "[w]hy take the test and dwell on what the test results
are and waste more time? Because now, I have four children. And my focus right
now is the importance of all those children and my wife." Id.
9 "Hypertrophic cardiomyopathy" ("HCM") is an incurable form of heart
disease characterizedby a thickening of the heart muscle. Siebert, supra note 74,
at 50. "Victims commonly suffer from chest pain, shortness of breath, dizziness
and fainting spells. Over time, HCM often leads to congestive heart failure. It
can also cause sudden death, most commonly in the young. Death, in fact, is
often HCM's first symptom." Siebert, supra note 74, at 50.
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years ago; two of their four cousins have HCM ...
Fortunately, neither of my children has HCM, but each
may carry the defective gene. When they are adults they
will have to decide whether to undergo genetic testing to
avoid passing HCM on to their children. As ... I did, they
will make this choice themselves.9"
Additionally, genetic testing may cause adverse psychological
consequences. As genetic diseases are generally immutable,9'
90 Thea L. Volpe, Letters, N.Y. TIMEs, Oct. 15, 1995, § 6 (Magazine), at 16.
According to a March of Dimes poll, out of 1,000 people questioned:
* 64[%] said they'd have a test during pregnancy to determine if
the fetus has a genetic disease; 32[%] said they wouldn't test.
* 79[%] said they'd have genetic tests before conceiving to discover
if offspring might inherit a fatal genetic disease; 72[%] said
they'd test their children for genetic risks.
* 38[%] would ban new genetic tests until privacy-of-information
laws exist.
Parent Poll, CHILD, Mar. 1995, at 59, 59. In addition, when one survey posed
the question of whether to test a five-year-old for Huntington's disease at the
parents' request, only two out of 49 geneticists (4%) said they would comply,
while 100 out of 189 pediatricians (53%) said they would do the test. George J.
Annas, Genetic Prophecy & Genetic Privacy, TRIAL, Jan. 1996, at 18, 20. If a
doctor recommends a genetic test, an individual should ask the following
questions about the testing:
* Why are you suggesting the test?
* What does the test detect?
* How will having the results, either positive or negative, change
your advice to me about treatment or overall medical care?
* How could my being tested affect my children or other family
members? Should I disclose the results to them?
* Has the test been approved by the Food and Drug Administration?
(The best use of experimental tests may be uncertain).
* How much does the test cost?
* Will my insurance pay for the test? (You may or may not choose
to submit a claim).
Who will have access to my test results now and in the future?
Ince, supra note 5, at 4.
" "Generally immutable" refers to the fact that an individual's genetic
blueprint cannot be altered. However, environmental factors may prevent the
manifestation of a genetic disorder. See notes and accompanying text supra pp.
569-71 (discussing environmental factors that affect a person's health).
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people carrying defective genes may view themselves as
defective.92 Many people with defective genes feel stigmatized
despite the fact that they may never develop a disease. 93 In
addition, carriers of abnormal genes often experience confusion,
alienation and depression after being tested.94 Mandatory genetic
testing compounds psychological harm because an individual would
be forced to learn about the information. 95 Thus, if insurance
companies mandate genetic testing, individuals will learn about
their defective genes and will lose their freedom not to know.
96
92 ASSESSING GENETIC RISKS, supra note 2, at 257.
" Do You Want to Know?, supra note 87, at 3. In addition, forcing people
to learn their genetic makeup can lead to stigma. This was found on the island
of Orchemonos in Greece where there was a high incidence of sickle cell anemia,
an automsomal recessive genetic disorder. Lori B. Andrews, Genetic Fallout:
New Technologies Are Changing the Legal Landscape, TRIAL, Dec. 1995, at 20,
23 (citing George Stamatoyannapoulous, Problems with Screening and
Counseling in the Hemoglobinopathies, in BIRTH DEFECTS: PROCEEDINGS OF THE
FOURTH INTERNATIONAL CONFERENCE 268,274 (A.G. Motulski & F.J.G. Ebling
eds., 1974)). Health care workers tested the island population so that carriers
would not marry other carriers. Id. This was done because a child could only get
the disease if both parents carried the sickle cell gene. Id. "When the workers
later returned to the island, they found that the carriers had been so stigmatized
that no noncarriers would marry them. Instead, carriers lied about their status or
married other carriers, thus increasing the number of affected children." Id.
9' Do You Want to Know?, supra note 87, at 3. For example, a woman in
her forties who tested positive for Alzheimers's disease "reacted 'with anxiety,
sorrow, depressive feelings and, for a period of a month, suicidal thoughts."'
Robin McKie, New Genetic Forecast Led Woman to Suicide Brink, OBSERVER,
Feb. 5, 1995, at 2. Another individual in Minnesota committed suicide after
obtaining negative genetic test results about Huntington's disease over the phone.
Saltus, supra note 37, at 28.
9' ASSESSING GENETIC RISKS, supra note 2, at 257.
96 See David Ballingrud, Gene Testing Raises Fears of Insurance Discrimi-
nation, ST. PETERSBURG TIMES, June 4, 1995, at 14A. However, insurers argue
that serious errors in risk classification would result if insurance companies were
unaware of important and unfavorable information known to applicants.
Pokorski, supra note 46, at 47. "Some people would get their insurance at
unreasonably low cost. More claims would be filed than were expected by the
insurer. And if the insurer made a significant number of risk classification errors,
the financial status of the entire insurance pool would be significantly affected."
Pokorski, supra note 46, at 47.
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New times demand new measures and new men;
The world advances, and in time outgrows
The laws which in our fathers' times were best;
And doubtless, after us, some purer scheme
Will be shaped out by wiser men than we,
Made wiser by the steady growth of truth.
-James R. Lowell97
Health insurance is a necessity,98 and excessive premiums or
17 A Glance Behind the Curtain, reprinted in SELDES, supra note 1, at
568-69.
9 See Daniel Callahan, Symbols, Rationality, and Justice: Rationing Health
Care, 18 AM. J.L. & MED. 1 (1992) (proposing an ideal American health care
system whereby every American is guaranteed an adequate and affordable level
of health care); Ivette Mendez, Legislators Go to Bat for Privatized Workers,
STAR-LEDGER, June 7, 1995, at 17 (quoting New Jersey State Senator Wayne
Bryant for the proposition that New Jersey, under the guise of privatization,
should not deprive direct service employees of the basic necessity of health
insurance).
Universal health care was one of the preeminent issues of President
Clinton's election campaign. He originally defined universal health care as
"functional full coverage [that would cover] 96, 97, 98 percent" of Americans.
Mark Z. Barabak, President Bends on Health Care, SAN DIEGO UNION-TRIB.,
July 20, 1994, at Al. Following the President's lead, both the United States
Senate and the House of Representatives introduced the Health Security Act on
November 20, 1993. S. 1757, 103d Cong., 1st Sess. (1993); H.R. 3600, 103d
Cong., 1st Sess. (1993). The purpose of the legislation was:
to ensure individual and family security through health care coverage
for all Americans in a manner that contains the rate of growth in health
care costs and promotes responsible health insurance practices, to
promote choice in health care, and to ensure and protect the health care
of all Americans.
Id. The bill contained over 1300 pages, and "[tihe drafting effort took
approximately eleven months and involved about ten attorneys." Sara
Rosenbaum, Symposium: Setting a Place for Ed Sparer at the National Health
Reform Table, 60 BROOK. L. REv. 71, 72 (1994). However, "[a]fter months of
heated discussion, the latest round of the national health care debate ended in
Congress ... without passage of any reform legislation." Note, UniversalAccess
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the denial of health insurance altogether should not burden
individuals because they might have an increased risk of suffering
from a particular disease. 99 A large portion of the United States
population could become uninsurable if insurers are allowed to use
genetic testing.' "Since private health insurance is the means by
which this country pays for health care, uninsurability means a
denial of health care for a large number of people."' 1 According
to a report of the multidisciplinary Committee on Assessing Genetic
Risks,' O2
to Health Care, 108 HARV. L. REv. 1323, 1323 (1995) [hereinafter Note]. See
supra note 65 (discussing current health care proposals). See generally Cathie Jo
Martin, Stuck in Neutral: Big Business and the Politics of National Health
Reform, 20 J. HEALTH POL. POL'Y & L. 431 (1995) (discussing the lack of "big
business" participation in health care reform); Arnold J. Rosoff, The Role of
Clinical Practice Guidelines in Health Care Reform, 5 HEALTH MATRIX 369
(1995) (reviewing the development of the clinical practice guideline movement
and its "implications for health care reform at all levels. . ."); Sven Steinmo &
Jon Watts, It's the Institutions, Stupid! Why Comprehensive National Health
Insurance Always Fails in America, 20 J. HEALTH POL. POL'Y & L. 329 (1995)
(discussing American political institution bias against comprehensive national
health insurance); Note, supra (discussing "the prospects for and the problems
with justifying universal access to health care in late twentieth-century
America").
99 Leo Uzych, Is Big Brother Closing in? Genetic Testing Could Demolish
Broad Access to Health Care, PENN. L.J., Aug. 23, 1993, at 2.
10 Cushing, supra note 47, at 262.
01 Cushing, supra note 47, at 262. Accordingto Mary-Claire King, professor
of genetics and epidemiology at the Universtiy of California at Berkely, everyone
is predisposed to some type of disease and "as we become better at [testing], we
would have to remove everyone from the insurance pool." Daniel J. Lehman,
Genetic Tests Called a Threat to Privacy, CHIC. SUN-TIMES, Oct. 10, 1995, at
8.
"o2 The Committee on Assessing Genetic Risks, jointly supported by the
Institute of Medicine of the National Academy of Sciences, the National Center
for Human Genome Research at the National Institutes of Health ("NIH") and
the Department of Energy, Health Effects Program of the Life Science Research
Office ("DOE"), held a series of workshops and meetings on the many phases
and impacts of genetic testing. ASSESSING GENETIC RISKS, supra note 2, at v-vi.
A report was written that was based on information from experts, the public,
scientific and policy literature and discussions at committee meetings. ASSESSING
GENETIC RISKS, supra note 2, at v-vi.
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[b]ecause health insurance differs significantly from other
types of insurance in that it regulates access to health care,
an important social good, risk-based health insurance
should be eliminated. A means of access to health care
should be available to every American without regard to
the individual's present health status or condition, including
genetic makeup. Any health insurance reform proposals
need to be evaluated to determine their effect on genetic
testing and the use of genetic information in health
insurance.' 03
Until medical underwriting is no longer performed, legislation is
necessary to protect people from genetic discrimination and to
ensure privacy.104 The following sections will discuss enacted and
proposed legislation concerning genetic testing and insurance. Part
A will review federal legislation, and part B will survey state
legislation.
103 ASSESSING GENETIC RISKS, supra note 2, at 281.
104 In July 1995, the National Action Plan on Breast Cancer and the
NIH-DOE Ethical, Legal, and Social Implication of Human Genome Research
Working Group ("ELSI") cosponsored a workshop on genetic discrimination and
health insurance. Hudson, supra note 44, at 393 (citing Genetic Discrimination
and Health Insurance: A Case Study on Breast Cancer (Workshop, Bethesda,
MD, July, 11, 1995)). The workshop developed the following recommendations
for state and federal lawmakers to protect against genetic discrimination:
1) Insurance providers should be prohibited from using genetic
information, or an individual's request for genetic services, to
deny or limit any coverage or establish eligibility, continuation,
enrollment, or contribution requirements.
2) Insurance providers should be prohibited from establishing
differential rates or premium payments based on genetic infor-
mation or an individual's request for genetic services.
3) Insurance providers should be prohibited from requesting or
requiring collection or disclosure of genetic information.
4) Insurance providers and other holders of genetic information
should be prohibited from releasing genetic information without
prior written authorization of the individual. Written authorization
should be required for each disclosure and include to whom the
disclosure would be made.




Federal legislation prohibiting insurers from using genetic
information for insurance coverage has yet to be enacted. The first
legislation introduced on the federal level to protect genetic
information was the Human Genome Privacy Act of 1990.1°5 No
other federal bills were proposed until the end of 1995. Then,
within a five month period, six different bills regulating genetic
information were introduced. 10 6 Three bills, the Genetic Privacy
and Nondiscrimination Act of 1995,107 the Genetic Information
Nondiscrimination in Health Insurance Act of 1995108 and the
Genetic Fairness Act of 1996,109 were proposed to protect
individuals against genetic discrimination. In addition, three bills
introduced to improve the "portability and continuity of health
insurance coverage" include restrictions on the use of genetic
information for health insurance.10°
Representative John Conyers (D-MI) introduced the Human
Genome Privacy Act on September 13, 1990."' According to
Representative Conyers, "[p]ublic release of people's genetic
information is a Pandora's Box that is best left unopened.""' The
purpose of the bill was to "safeguard individual privacy of genetic
10' H.R. 5612, 101st Cong., 2d Sess. (1990). The Human Genome Privacy
Act was not enacted because "[i]n October, 1992, Congress adjourned sine di[e].
Thus, all unpassed bills pending at that time died." Smith & Burns, supra note
81, at 53 n.160. This bill was not reintroduced.
106 S. 1416, 104th Cong., 1st Sess. (1995); H.R. 2690, 104th Cong., 1st Sess.
(1995) (identical to S. 1416); H.R. 2748, 104th Cong., 1st Sess. (1995); S. 1600,
104th Cong., 2d Sess. (1996); H.R. 3043, 104th Cong., 2d Sess. (1996); 3103,
104th Cong., 2d Sess. (1996); H.R. 3160, 104th Cong., 2d Sess. (1996)
(combined with H.R. 3103); H.R. 3185, 104th Cong., 2d Sess. (1996).
107 S. 1416; H.R. 2690 (identical bills).
'o' H.R. 2748.
109 S. 1600.
110 Working Families Health Access Act of 1996 or H.R. 3043; Health
Coverage Availability and Affordability Act of 1996 or H.R. 3103/3160; Health
Insurance Reform Act of 1996 or H.R. 3185.
... H.R. 5612.
112 Douglas A. Levy, Experts Callfor Genetic Privacy Legislation, UPI, Oct.
18, 1991, available in LEXIS, Nexis Library, ARCNWS File.
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information from the misuse of records maintained by agencies or
their contractors or grantees for the purpose of research, diagnosis,
treatment, or identification of genetic disorders ....""'
Although the Human Genome Privacy Act protected genetic
privacy, it contained many weaknesses. The greatest weakness was
that it only prohibited disclosure from government agencies, and
did not prohibit disclosure from other sources." 4 The bill, if
passed, also would have given insurance companies the ability to
discover genetic information."5 One provision permitted dis-
closure of genetic information without authorization to medical
professionals if the information was used for treatment of a specific
individual." 6 Doctors working for an employer's Health Mainte-
nance Organization ("HMO")"' carrier would record this
disclosed information on the individual's medical file, where it
could be subject to discovery"' because "both the current system
of health care financing and the multitude of people with direct
access to patients' records, especially in institutional settings,
seriously compromise the traditional notion of medical
confidentiality.""' 9 Moreover, many policyholders are required to
113 H.R. 5612. According to the congressional findings:
the opportunities for an individual to secure education, employment,
health care, insurance, and credit, and his or her right to due process
and other legal protections are endangered by the misuse of genetic
information systems [and] in order to protect the genetic privacy of
individuals in informational systems maintained by agencies, it is
necessary and proper for the Congress to regulate the collection,
maintenance, use and dissemination of information by such agencies.
Id § 2(a)(4), (5).
14 Id §§ 101(1); 114. See O'Hara, supra note 72, at 1227.
"' O'Hara, supra note 72, at 1226.
116 H.R. 5612 § 123(a). See O'Hara, supra note 72, at 1226.
"'7 A Health Maintenance Organization ("HMO") is defined as "a type of
managed care health plan that requires members to seek care from a limited
network of hospitals and doctors .... In return for giving up freedom of doctor
choice, HMOs offer significant financial benefits." Tim Bonfield, Seniors Face
HMO Blitz; Big Changes in Medicare May Save Money, but Will They Maintain
Quality?, CINCINNATI ENQ., Nov. 19, 1995, at Al.
18 O'Hara, supra note 72, at 1226-27.
"J Allen & Moseley, supra note 18, at 68. On November 14, 1995, Senators
Robert F. Bennett (R-UT) and Patrick Leahy (D-VT) held hearings on the
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sign releases that permit insurance companies to access "any and all
records," so information placed in a medical file would be
discoverable. 120
Over four years passed before genetic information issues once
again reached the federal level. In March 1995, the Equal Employ-
ment Opportunity Commission ("EEOC") extended the coverage
under the Americans with Disabilities Act ("ADA")121 to include
individuals who are regarded as having genetic impairments. 122
The EEOC released guidelines which clarified the definition of
"disability" under the ADA to include "individuals who are
subjected to discrimination on the basis of genetic information
relating to illness, disease, or other disorders.' ' 123 However, in
Medical Records Confidentiality Act, a bill "intended to establish uniform
Federal rules for the use and disclosure of health information ... ." Gina Kolata,
When Patients' Records Are Commodities for Sale, N.Y. TIMEs, Nov. 15, 1995,
at Al, C14. According to Senator Bennett, "the bill would give Americans
'greater confidentiality and greater access to see their own records."' Id. at Al.
However, critics of the bill argue that it "would supersede state laws, making it
easier to set up national medical databases, and would set a dangerously loose
standard of accessibility to patients' records." Id. at C 14. The bill does not cover
the use of genetic information. See S. 1360, 104th Cong., 1st Sess. (1995);
Beverly Woodward, Patients' Privacy at Risk, N.Y. TIMEs, Nov. 15, 1995, at
A23 (criticizing the proposed bill); see also Lawrence 0. Gostin et al., Privacy
and Security of Health Information in the Emerging Health Care System, 5
HEALTH MATRIX 1 (1995) (discussing "the objectives for the collection, storage,
and use of information in the health care system and the means to attain those
objectives").
120 Cotton, supra note 52, at 93-95.
.2 Pub. L. No. 101-336, 104 Stat. 327 (codified as amended at 42 U.S.C.
§§ 12101-12213 (1990)).
122 Executive Summary: Compliance Manual Section 902, Definition of the
Term "Disability," EEOC Order 915.002, Mar. 14, 1995, at 902-45 [hereinafter
Compliance Manual]. See Abbey S. Meyers, EEOC Genetic Ruling Protects
Society, 4 EMPL. TESTING L. & POL'Y REP., 103, 103 (1995); Rick Weiss, Gene
Discrimination Barred in Workplace; EEOC Says Jobs Can't Be Denied Based
on Predisposition to Disease, WASH. POST, Apr. 7, 1995, at A3.
123 Compliance Manual, supra note 122, at 902-45. The ADA definition of
"disability" includes "with respect to an individual-(A) a physical or mental
impairment that substantially limits one or more of the major life activities of
such individual; (B) a record of such an impairment; or (C) being regarded as
having such an impairment." 42 U.S.C. § 12102(2). The third part of the
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order to qualify, an individual must both show that an employer
regarded the individual as having a genetic defect, and "acted on
that basis."'' 24 Although federal legal protection now exists for
employment discrimination based on perceived genetic impair-
ments, the EEOC has not specifically determined whether a
potential employer can deny an applicant a job because the
individual, although completely healthy, carries a defective gene
which can pass to the applicant's offspring, and the employer does
not want to pay future health care costs associated with the
children. 125
The first legislation since the Human Genome Privacy Act was
introduced on November 15, 1995, by Senator Mark Hatfield (R-
OR). 26 Senator Hatfield proposed the Genetic Privacy and
Nondiscrimination Act of 1995,127 which would establish limi-
tations "with respect to the disclosure and use of genetic informa-
tion.' 2 ' Two weeks later, Representative Clifford Steams (R-FL)
definition applies to individuals subjected to discrimination based on a genetic
impairment. Compliance Manual, supra note 122, at 902-45. Thus, employers
who make adverse employment decisions based solely on genetic predisposition
violate the ADA because they regard an applicant as having an impairment. New
EEOC Guidelines Clarify Disability, HUMAN GENOME NEWS, July-Aug. 1995,
at 4. See Dee Lord, Something in the Genes, A.B.A. J., Apr. 1996, at 86
(discussing the recent EEOC "steps to forestall discrimination for predisposition
to illness").
124 Compliance Manual, supra note 122, at 902-46.
125 Andrews, supra note 93, at 25.
126 S. 1416.
127 Senator Mark Hatfield (R-OR) based the legislation on Oregon's genetic
privacy act. See Liefer, supra note 50, at 10; discussion of Oregon law infra pp.
602-03; see also The Genetic Privacy Act (Feb. 28, 1995) (Available on the
Internet from the Universal Resource Locator: http://www-busph.bu.edu/Depts/
HealthLaw/). The Genetic Privacy Act is a proposal for federal legislation that
governs the collection, analysis, storage and use of DNA samples, and the genetic
information that results from this DNA. Id. The proposal was authored by
George Annas, Leonard Glantz and Patricia Roche of the Health Law Depart-
ment, Boston University School of Public Health, with funding provided by NIH-
DOE ELSI. See Annas, supra note 90, at 22-24 (highlighting the Genetic Privacy
Act).
128 S. 1416. The purpose of the Genetic Privacy and Nondiscrimination Act
is to "(1) define the rights of individuals whose genetic information is disclosed;
(2) define the circumstancesunder which an individual's genetic information may
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sponsored the identical bill in the House of Representatives.29
The legislation would protect individual privacy, and prohibit
discrimination by insurers and employers based on an individual's
genetic information.13 The bill states that "[a]n insurer offering
health insurance may not use genetic information' to reject,
deny, limit, cancel, refuse to renew, increase the rates of, or
otherwise affect health insurance."'' 32 Insurers, other than those
issuing health insurance, would be permitted to request an applicant
to take a genetic test. 133 However, an insurer would need specific
written consent from an applicant in order to use the test
results.3 4 In addition, an insurer could not induce the purchase
of insurance based on a genetic test. 135
On December 7, 1995, Representative Louise Slaughter (D-NY)
proposed a similar bill 36 which would "prohibit insurance
providers from denying or canceling health insurance coverage, or
varying the premiums, terms, or conditions for health insurance
be disclosed; and (3) protect against discrimination by an insurer or employer
based upon an individual's genetic information." Id. § 2(B). According to
Senator Connie Mack (R-FL), cosponsor of the Senate bill, "[t]he science of
genetic testing is moving at a rate that far outpaces our understanding of how to
apply the discoveries once they're made. . . . Regardless of the tremendous
advances in the science, we must ensure that genetic tests remain voluntary and
completely private." Connie Mack, Genetic-Test Balance, ORLANDO SENTINEL,
Feb. 4, 1996, at G2.
29 H.R. 2690. This bill was introduced on Nov. 29, 1995. Id.
130 S. 1416 § 2(B); H.R. 2690 § 2(B).
' "Genetic information" is defined as "the information about genes, gene
products or inherited characteristics that may derive from an individual or a
family member." S. 1416 § 3(4); H.R. 2690 § 3(4).
132 S. 1416 § 6(a); H.R. 2690 § 6(a).
' S. 1416 § 6(C); H.R. 2690 § 6(C). "Genetic test" is defined as "a test for
determining the presence or absence of genetic characteristics in an individual,
including tests of nucleic acids such as DNA, RNA and mitochondrial DNA,
chromosomes or proteins in order to diagnose a genetic characteristic." S. 1416
§ 3(5); H.R. 2690 § 3(5).
134 S. 1416 § 6(C); H.R. 2690 § 6(C).
1 S. 1416 § 6(B); H.R. 2690 § 6(B).
136 RepresentativeLouise Slaughter introduced the Genetic Information Non-
discrimination in Health Insurance Act of 1995 or H.R. 2748. The scope of the
legislation is limited to discrimination by health insurers. Id
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coverage on the basis of genetic information'37 or a request for
genetic services."' 38 Representative Slaughter found that insurance
carriers refuse health insurance coverage to people if a genetic
condition runs in their family, and that the problem could worsen
with the "rapid advances in gene mapping."'39 Representative
Slaughter announced the legislation at a news conference which
focused on breast cancer. 4 ° The bill follows recommendations
from a recent meeting of scientists, health officials and insurance
industry representatives.' 4' However, a spokesman for the Health
Insurance Association of America indicated that insurers are not
sure if they can support the bill, and that they are "wary of
proposals that would limit their ability to assess an applicant's
medical history as a way of spreading the risk on individual
policies."142
Three months later, on March 7, 1996, Senator Dianne
Feinstein (D-CA) introduced the Genetic Fairness Act of 1996'
on behalf of herself and Senator Connie Mack (R-FL).114 The bill
would prohibit an insurer offering health care coverage from
terminating, restricting, limiting, canceling, refusing to renew,
varying rates, denying coverage or "otherwise" discriminating
against an individual or member of the individual's family on the
' "Genetic information" is defined as "information about genes, gene
products, or inherited characteristics." Id. § 2(e)(3).
13' H.R. 2748. "Genetic services" are "health services to obtain, assess, and
interpret genetic information for diagnostic and therapeutic purposes, and for
genetic education and couselling." Id. § 2(e)(4). Currently, New York does not
have laws against genetic discrimination in health insurance. John Machacek,
Slaughter Bill Protects People with Genes Linked to Serious Illness, GANNETT
NEWS SERVICE, Dec. 7, 1995, available in LEXIS, Nexis Library, CURNWS
File. See supra note 13 (listing pending legislation in New York).
' Machacek, supra note 138. According to Representative Slaughter, "[tihis
is an issue not unknown to a number of people here, who have lost a spouse [to
cancer]. They would like very much to see something happen." Machacek, supra
note 138.
140 Machacek, supra note 138.
'4' Machacek, supra note 138. See supra note 104 (discussing the workshop
on genetic discrimination and health insurance).





basis of genetic information"' or a "request for or receipt of
genetic services."' 4 6 In addition, an insurer offering health care
coverage could not require an applicant or member already covered
"to be the subject of a genetic test or to be subjected to questions
relating to genetic information."' 47
In March 1996, several House bills introduced to provide
greater access to health care also contained genetic information
provisions. 4 8 The provisions are similar to those contained in the
Health Coverage Availability and Affordability Act of 1996, which
the House of Representatives passed on March 28, 1996.149 A
striking section in this legislation states that "genetic information
shall not be considered to be a preexisting condition . . . ,,'. In
addition, the bill prohibits a group health plan' and "an insurer
or HMO offering health insurance coverage in connection with a
group health plan" from denying coverage or varying rates on the
14s Id. § 3(a). "Genetic information" is defined as "information about genes,
gene products or inherited characteristicsthat may be derived from an individual
or a family member." Id. § 2(2).
146 Id. § 3(a). "Genetic services" are defined as "health services provided to
obtain, assess, and interpret genetic information for diagnostic and therapeutic
purposes, and for genetic education and counseling." Id. § 2(3).
147 Id. § 3(b).
14' H.R. 3043; H.R. 3103 (substituted and combined with H.R. 3160); H.R.
3185.
149 H.R. 3103. The Health Coverage Availability.and Affordability Act was
amended by H.R. Res. 392, 104th Cong., 2d Sess. (1996), which substituted and
combined the bill with H.R. 3160. When introduced, H.R. 3103 did not contain
any genetic information provisions.
"50 H.R. 3103/3160 § 101(B)(1)(B). According to Martha Volner, the
Alliance of Genetic Support Groups' director of health policy, "[iut's a piece of
legislation whose time has come." Elizabeth Neus, Bill Ensures Your Genes
Won't Cost You Insurance, SALT LAKE TRIB., Mar. 30, 1996, at Al.
The Working Families Health Access Act of 1996 or H.R. 3043 also limits
the use of genetic information as a preexisting condition. According to the bill,
"information relating to one's genetic predisposition alone shall not be considered
to be a preexisting condition. . . ." Id. § 4988(C)(2).
"' A "group health plan" is defined as "an employee welfare benefit plan
to the extent that the plan provides medical care . . .to employees or their
dependents ... directly or through insurance, reimbursement, or otherwise..
H.R. 3103/3160 § 191(a)(1).
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basis of health status, which includes genetic information. 52
Companies that offer health insurance coverage in the "small or
large group market,"'53  would also be prohibited from
discontinuing or refusing to renew coverage on the basis of health
status. 15 4  Moreover, individual health insurance coverage'55
would be guaranteed "to certain individuals with prior group
'S Id. § 103(a), (b). "Health status" refers to an individual's "medical
condition, claims experience, receipt of health care, medical history, genetic
information, evidence of insurability (including conditions arising out of acts of
domestic violence), or disability." Id. § 191(C)(6). "Genetic information" is not
defined in the legislation.
The Health Insurance Reform Act of 1996 or H.R. 3185 has the identical
definition of "health status." H.R. 3185 § 100(9). In addition, this bill prohibits
a health plan issuer offering a group health plan or an individual health plan
from refusing or discontinuing coverage based on the health status of an
individual. Id. §§ 101(1), 110(a), 11 l(b)(C).
The Working Families Health Access Act of 1996 or H.R. 3043 also
contains a provision limiting discrimination based on health status. According to
the legislation:
a group health plan and a carrier offering health insurance coverage in
connection with such a plan may not establish or impose eligibility,
continuation, enrollment, or contribution requirements for an individual
based on factors directly related to health status, genetic predisposition,
medical condition, claims experience, receipt of health care, medical
history, disability, or evidence of insurability of the individual.
Id. § 4987(a). A similar provision applies to health insurers offering individual
health care coverage. Id. § 4987(B).
13 A "large group market" is "the market for health insurance coverage
offered to employers (other than small employers) on behalf of their employees
(and their dependents) . . . ." H.R. 3103/3160 § 191(e)(2). A "small group
market" is "the health insurance market under which individuals obtain health
insurance coverage (directly or through any arrangement) on behalf of themselves
(and their dependents) on the basis of employment or other relationship with
respect to a small employer. . . ." Id. § 191(e)(4).
114 Id. § 132(B)(5).
"5 "Individual health insurance coverage" is defined as "health insurance
coverage offered to individuals if the coverage is not offered in connection with
a group health plan (other than such a plan that has fewer than two participants
as current employees on the first day of the plan year)." Id. § 191(C)(7).
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coverage."' 56 However, nonqualifying individuals would not be
covered under the Act.1
57
The federal bills specifically introduced to protect individuals
against genetic discrimination are comprehensive, and the passage
of any of the bills would effectively prevent genetic discrimination
by health insurers. 151 In fact, the bills' prohibitions against using
"genetic information" would prevent health insurers from relying
on information they currently use in medical underwriting.' The
definitions of genetic information include "inherited character-
istics," which could not be used by insurers when making health
coverage decisions. 60 Thus, insurers could not take into account
hereditary information obtained through medical questionnaires
based on family history of disease.' Enactment of this type of
156 Id § 141.
157 A "qualifying individual" is defined as an individual:
(A) (I) for whom, as of the date on which the individual seeks
coverage under this section, the aggregate of the qualified
coverage periods [aggregate health insurance coverage without a
lapse of 60 days] is 18 or more months and (II) whose most
recent prior coverage was under a group health plan, govern-
mental plan, or church plan (or health insurance coverage offered
in connection with any such plan);
(B) Who is not eligible for coverage under (I) a group health plan,
(II) part A or part B of Title XVIII of the Social Security Act, or
(III) a state plan under Title XIX of such Act (or any successor
program), and does not have individual health insurance coverage;
(C) With respect to whom the most recent coverage within the
coverage period described in subparagraph (A)(I) was not
terminated based on [nonpayment of premiums or fraud];
(D) If the individual had been offered the option of continuation
coverage under a COBRA continuation provision or under a
similar state program, who elected such coverage; and
(E) Who, if the individual elected such continuation coverage, has
exhausted such continuation coverage.
Id. § 141(b)(1).
158 See S. 1416, H.R. 2690, H.R. 2748, S. 1600.
1' See supra note 68 (discussing family history in medical underwriting).
160 See, e.g., S. 1416 § 3(4); H.R. 2748 § 2(e)(3); S. 1600 § 2(2).
161 Passage of a federal bill specifically proposed to combat genetic
discrimination would prevent insurers from taking into account any hereditary
information of any individual or individual's family. This interpretation is
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legislation is exactly what is needed to prevent genetic discrimi-
nation. Although the bill passed by the House of Representatives
offers some protection,162 many individuals are not covered under




Before 1986, state laws prohibiting genetic discrimination were
extremely limited in scope, and did not cover a large range of
genetic conditions.1 6' The first state laws only addressed specific
genetic traits such as hemoglobin C 65 or sickle cell traits. 66
supported by the language of Oregon's genetic privacy act, which was the basis
of the Genetic Privacy and Nondiscrimination Act of 1995. See Liefer, supra
note 50, at 10. The Oregon law defines "genetic information" as "information
about an individual or family obtained from: (a) A genetic test; or (b) An
individual's DNA sample." OR. REV. STAT. § 659.700(4). However, the proposed
federal laws do not limit genetic information to genetic tests or DNA samples.
See S. 1416; H.R. 2690; H.R. 2748; S. 1600. The definition of "genetic infor-
mation" is broad and includes any information on inherited characteristics. S.
1416; H.R. 2690; H.R. 2748; S. 1600.
162 See H.R. 3103/3160.
163 The McCarran-Ferguson Act permits states to regulate insurance. See Act
Mar. 9, 1945, ch. 10, 59 Stat. 33 (codified as amended at 15 U.S.C. §§ 1011-
1015 (1956)). However, states cannot directly regulate self-insured employee
benefit plans under the Employee Retirement Income Security Act ("ERISA"),
see Pub. L. No. 93-406, 88 Stat. 832 (codified as amended at 29 U.S.C. § 1144
(1993)), and "about half of all employer-provided policies are exempt from state
regulations because the companies are self-insured. . . ." Ince, supra note 5, at
5. See McClure, supra note 38, at 233 (discussing insurance law and authority);
see also Devon P. Groves, ERISA Waivers and State Health Care Reform, 28
COLUM. J.L. & SOC. PROB. 609, 620-26 (1995) (examining ERISA preemption
with respect to health insurance); Jerry L. Mashaw & Theodore R. Marmor,
Federalism and Health Care: A Reply, 28 CONN. L. REV. 161 (1995) (supporting
a proposal to eliminate the preemption of state regulation of employer-funded
insurance under ERISA).
164 See, e.g., MD. CODE ANN., INS. § 223. This law, enacted in 1986, only
covers genetic "traits." Id. § 223(b)(4). A "trait" is defined as "a qualitative
characteristic; a discrete attribute as contrasted with metrical [of or relating to
measurement] character." MEDICAL DICTIONARY, supra note 7, at 1835.
16' Hemoglobin C is caused by an abnormal hemoglobin which reduces the
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However, since 1990, with the start of the Human Genome
Project,167 ten states have enacted laws that protect against
genetic discrimination for most genetic conditions. 168 Moreover,
since 1986, the trend of enacted and proposed legislation has
moved, and is moving, in a more comprehensive direction, giving
greater protection against genetic discrimination to individuals in
the area of health insurance. 169 At the same time, state legislatures
opted to focus only on health and not life insurance. Less emphasis
is given to life insurance protection, and the trend is moving away
from restrictions (albeit limited in the first place) on the use of
genetic information in life insurance policies. 170 The following
section surveys statute proposals, and state laws in order of
enactment to show the trend in the state legislation.
1. Maryland
As early as 1986, Maryland's unfair discrimination statute
covered genetic traits. 71 The statute prohibits life and health
insurers from making any differential in ratings, premium payments
or dividends solely because an applicant or policyholder has a
normal plasticity of red blood cells. MEDICAL DICTIONARY, supra note 7, at 778.
.66 See Hudson, supra note 44, at 393 n.8 (citing single genetic trait
discrimination laws); see, e.g., ALA. CODE § 27-5-13 (1986); FLA. STAT. ANN.
§ 626.9707 (West 1984); N.C. GEN. STAT. § 58-65-70 (1994).
167 See supra note 18 (discussing the Human Genome Project).
168 See Hudson, supra note 44, at 392. See CAL. CIV. CODE § 56.17; CAL.
INS. CODE §§ 10123.3, 10123.31, 10123.35, 10140, 10140.1, 10140.5, 10143,
10146, 10147, 10148, 10149, 10149.1, 11512.95, 11512.96, 11512.965; CAL.
HEALTH & SAFETY CODE §§ 1374.7, 1374.9; COLO. REV. STAT. § 10-3-1104.7;
FLA. STAT. ANN. § 760.40; GA. CODE ANN. §§ 33-54-1 to 8; MiNN. STAT. ANN.
§ 72A.139; MONT. CODE ANN. § 33-18-206; N.H. REV. STAT. ANN. §§ 141-H:1
to 6; OHIO REV. CODE ANN. §§ 1742.42, 1742.43, 3901.49, 3901.491, 3901.50,
3901.501; OR. REv. STAT. §§ 659.700, 659.705, 659.710, 659.715, 659.720,
746.135; WIS. STAT. ANN. § 631.89.
169 See Table 1 and discussion infra pp. 603-08 (comparing state restrictions
on the use of genetic information by health insurers).
170 See Table 1 and discussion infra pp. 603-08 (comparing state restrictions
on the use of genetic information by life insurers).
171 MD. CODE ANN., INS. § 223.
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particular genetic trait.'72 These traits include "sickle-cell trait,
thalassemia-minor trait, 173 hemoglobin C trait, Tay-Sachs
trait,'74 or any genetic trait which is harmless within itself, unless
there is actuarial justification."' 75 However, the statute does not
protect information disclosure, and only covers these limited
genetic conditions.
Pending legislation introduced on January 25, 1996176 would
establish greater protections against genetic discrimination to
individuals in Maryland for health insurance. 177 The bill states
that an insurer, nonprofit health service plan, or HMO could not
"use genetic information 171 to reject, deny, limit, cancel, refuse
to renew, increase the rates of, affect the terms or conditions of, or
otherwise affect a health insurance policy or contract."'1 79 In
addition, the statute would prohibit all of the above insurers from
requesting or collecting genetic information,8 ° or releasing
genetic information without prior written consent.'8' An
172 Id. § 223(a)(3), (b)(4).
173 Thalassemia-minoris a hemogloblin metabolism disorder which is usually
asymptomatic, and often has a "slightly reduced hemoglobin level with slightly
increased [red blood cell] count." MEDICAL DICTIONARY, supra note 7, at 1792-
93.
174 Tay-Sachs disease is a lysosomal ("membrane-bound vesicle" which
contains enzymes) storage disease. Blindness and seizures occur during the first
year of birth and death results "within a few years." MEDICAL DICTIONARY,
supra note 7, at 504, 1012.
' MD. CODE ANN., INS. § 223(a)(3), (b)(4). See supra note 46 (discussing
the determination of rates and premiums by insurance companies).
176 S.B. 276, 1996 Leg. Sess. (Md. 1996). Maryland State Senators Jennie
Forehand, Perry Sfikas, Delores Kelley, Leonard Teitelbaum, Ulysses Currie and
Donald Munson introduced the legislation. Id
177 Id. § 223.1(B).
171 "Genetic information" is defined as "information about the genes, gene
products, or inherited characteristics of an individual." Id. § 223.1 (A). See notes
and accompanying text supra pp. 587-88 (discussing the significance of the term
"genetic information" in pending federal legislation).
179 S.B. 276 § 223.1(B)(1).
IS0 Id. § 223.1(B)(2).
"81 Id. § 223.1(B)(3).
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individual harmed by a violation would be able to recover equitable
relief'82 and actual damages.'83
2. Arizona
In 1989, the Arizona legislature amended the state's unfair
discrimination statute to include genetic conditions.' 84 The law
prohibits life or disability insurers8 5 from refusing to consider
applications for insurance on the basis of a genetic condition. 86
The rejection or the determination of rates, terms or conditions of
life or disability insurance on the basis of a genetic test constitutes
unfair discrimination, unless "the applicant's medical condition and
history and either claims experience or actuarial projections
establish that substantial differences in claims are likely to result
from the genetic condition ... Health insurance is not
covered under this statute, and in any event, discrimination can
occur if there is actuarial justification.
3. Montana
In 1991, the Montana legislature amended the state's unfair
discrimination statute concerning life and disability insurers by
restricting the use of information based on genetic conditions.1
88
'82 Equitable relief includes "a retroactive order directing the insurer,
nonprofit health service plan, or health maintenance organization to provide
health insurance to the individual under the same terms and conditions that would
have applied had the violation not occurred." Id. § 223.1(C)(1).
183 Id. § 223.1(C)(1), (2).
184 ARiz. REV. STAT. ANN. § 20-448.
's Life insurers protect against "the economic loss resulting from the
unexpected death of the insured," while disability insurers pay benefits to an
insured individual because of "an impairment or handicap resulting from accident
or ill health, that prevents an individual from earning a living." MICHAEL
THOMSETT, INSURANCE DICTIONARY 115 (1989).
186 "Genetic condition" is defined as a "specific chromosomal or single-gene
genetic condition." ARIz. REV. STAT. ANN. § 20-448(F). See supra notes 32-33
(discussing chromosomal and single-gene abnormalities).
187 ARIz. REV. STAT. ANN. § 20-448(E).
18 MONT. CODE ANN. § 33-18-206. "Genetic condition" is defined as a
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However, the restrictions are limited, and only prohibit an insurer
from refusing to consider an application for life or disability
insurance.8 9 In addition, the rejection of an application or the
determination of rates based on a genetic condition do not
constitute unfair discrimination if "the applicant's medical condition
and history and either claims experience or actuarial projections
establish that substantial differences in claims are likely to result
from the genetic condition."' 90 There are no restrictions on the
use of genetic information for health insurance coverage.
4. Wisconsin
In 1991, the Wisconsin legislature passed a statute restricting
the use of genetic test results.' 91 According to Representative
Marlin Schneider, the author of the bill, the issue of genetic testing
is "the most important privacy issue ever."' 192 He argued that
individuals "ought not to be compelled to give up their genetic
code information for insurance purposes."' 93  Representative
Schneider's sentiment was codified in the statute, which prohibits
"an insurer, county, city, village or school board that provides
health care services for individuals on a self-insured basis" from
requesting or requiring an individual or family member to obtain
"specific chromosomal or single-gene genetic condition." Id § 33-18-206(5)(c).
See supra notes 32-33 (discussing chromosomal and single-gene abnormalities).
' MONT. CODE ANN. § 33-18-206(3). In addition, the law does not restrict
any disclosure of genetic information by insurers.
190 Id. § 33-18-206(4).
191 WIS. STAT. ANN. § 631.89. "Genetic test" is defined as "a test using
[DNA] extracted from an individual's cells in order to determine the presence of
a genetic disease or disorder or the individual's predisposition for a particular
genetic disease or disorder." Id. § 631.89(1). However, people who are
discriminated against on the basis of gene protein tests are not protected.
Andrews, supra note 93, at 25. Proteins are products of DNA, thus a protein test
is not covered under the definition of "genetic test." See notes and accompanying
text supra p. 557 (discussing proteins and their functions), and notes and
accompanying text infra p. 607 (comparing the different state law definitions of
"genetic testing").
92 Joe Manning, Gene Tests Bare What Ailments Lurk, MILWAUKEE J. &




a genetic test, reveal if a genetic test was taken or any results of
such a test.' 94 In addition, insurance coverage and health care
benefits cannot be conditioned on the above, or considered in the
determination of rates or any other aspect of coverage.' 95 These
prohibitions do not apply to life or income continuation
insurers, 196 however, life and income continuation insurers are
prohibited from using obtained information when writing any other
type of insurance coverage.197
On March 17, 1995, a bill was proposed to repeal and amend
certain sections of the Wisconsin statute in order to expand the
definition of "genetic test. '' 198 Genetic tests would include the
physical examination of an individual or an examination of the
individual's family history to determine if there is a genetic
disorder or predisposition to a genetic disease. 199 "Individual"
would include an unborn child.200 In addition, the proposal
specifies that the prohibitions restricting the use of genetic testing
by insurers would apply only to an insurer "that offers health care
coverage."' ' The restrictions on requesting or requiring a genetic
test would be repealed, but insurers could not condition coverage
or determine rates on the results of genetic tests in their
202underwriting process.
194 WIS. STAT. ANN. § 631.89(2).
195 Id.
196 Income continuation insurance provides "full or partial payment of the
financial loss of earnings incurred as a result of injury or illness .. " Wis.
STAT. ANN. § 40.62(1) (West 1992).
'9' Wis. STAT. ANN. § 631.89(3). Thus, a life insurer who obtains genetic
information in order to issue a life insurance policy cannot use this information
for health insurance coverage.
'98 A.B. 227, 92d Leg. Sess., 1995-96 Reg. Sess. (Wis. 1995). See supra
note 191 (defining "genetic test" as currently used in the Wisconsin statute).
199 A.B. 227 § 631.89(1)(A).
200 A.B. 227 § 631.89(1)(b).
201 A.B. 227 § 631.89(2)(bm).
202 The bill would limit the restrictions to the underwriting process, which
is defined as "the process of risk evaluation and selection conducted by an
insurer." See WIS. STAT. ANN. § 631.89(l)(d).
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5. Florida
The only legislation in Florida concerning genetic testing and
insurance was enacted in 1992.23 The law states that any person
who perfoms a DNA analysis or receives any information regarding
an analysis must give notice of the analysis or results to the
individual tested.2"4 The only mention of insurance is in the
statute's last section:
The notice must also state whether the information was
used in any decision to grant or deny any insurance,
employment, mortgage, loan, credit, or educational
opportunity. If the information was used in any decision
that resulted in a denial, the analysis must be repeated...
and if the first analysis is found to be inaccurate, the denial
must be reviewed.0 5
Thus, the statute only provides for information disclosure. Insurers
can use genetic information in insurance underwriting, so Floridians
are not afforded substantive protection.
However, proposed legislation introduced in January and
February 1996206 would prevent insurers from requiring or
soliciting genetic tests,20 7 using or reviewing genetic test results,
or considering an individual's decisions or actions relating to
genetic testing in any manner for any insurance purpose.08 These
provisions would not apply to life or disability income insurance
policies.20 9
203 FLA. STAT. ANN. § 760.40(3).
204 Id.
205 id.
206 S.B. 748, 1996 Reg. Sess. (Fla. 1996); H.B. 923, 1996 Reg. Sess. (Fla.
1996) (identical bills).
207 "Genetic test" is defined as "a test to determine the presence of mutations
or variations in an individual's DNA associated with clinically recognized
diseases or disorders by the analysis of: 1. Any portion of the individual's DNA;
or 2. Any gene product of the individual's DNA." S.B. 748 §§ 627.4301(1)(a),
760.40(1); H.B. 923 §§ 627.4301(1)(a), 760.40(1).
208 S.B. 748 § 627.4301(2)(a); H.B. 923 § 627.4301(2)(a).
209 S.B. 748 § 627.4301(2)(a); H.B. 923 § 627.4301(2)(a). According to
Florida Senator Howard Forman, sponsor of S.B. 748, "[ilt's a real-world [bill]
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6. Ohio
In 1993, the Ohio legislature enacted temporary genetic
screening and testing prohibition statutes.210 According to Repre-
sentative Wayne Jones, the sponsor of the legislation, "[g]enetic
makeup is not something anybody can control. If insurers have
access to this information, they'll abuse it." '' The statutes cover
health maintenance organizations, sickness and accident
insurers21 2 and self-insurers,2 3 and they prohibit these insurers
from requiring an individual to submit to a genetic screening or
testing,24 or taking into consideration or making inquires about
with common sense." Jay Weaver, Bill Forbids Gene Screening by Health
Insurance Groups, SUN-SENTINEL, Mar. 7, 1996, at 17A. According to Florida
Representative Tracy Staff, sponsor of H.B. 923, "[w]e have this burgeoning
technology that can be used to determine the predisposition of people's medical
status, but we don't have any guidelines for how this information should be
used." Id. However, an attorney representing the Health Insurance Association
of America stated that the bill "allows for an applicant to consider the results of
his genetic testing when he applies for health insurance, but it prevents us from
considering the same information." Id.
210 OHIO REV. CODE ANN. §§ 1742.42, 3901.49, 3901.50. These three laws
will remain in effect until February 9, 2004. As of that date they will be repealed
and replaced by OHIO REV. CODE ANN. §§ 1742.43, 3901.491 and 3901.501,
respectively, which would allow insurers to use genetic information obtained
after February 9, 2004. Id
2"1 Christine B. O'Malley, Insurance Gene Tests Face Restrictions, BUS.
FIRST, Sept. 27, 1993, at 17.
212 Sickness and accident insurance is "any policy, contract, or certificate of
insurance against loss or expense resulting from the sickness of the insured, or
from the bodily injury or death of the insured by accident, or both.. . ." OHIO
REV. CODE ANN. § 3923.01 (Anderson 1989).
213 "Self-insurer" is defined as a "government entity providing coverage for
health care services on a self-insurance basis." OHIO REV. CODE ANN. §3901.50.
214 "Genetic screening or testing" is defined as:
a laboratory test of a person's genes or chromosomes for abnormalities,
defects, or deficiencies, including carrier status, that are linked to
physical or mental disorders or impairments, or that indicate a
susceptibility to illness, disease, or other disorders, whether physical or
mental, which test is a direct test for abnormalities, defects, or
deficiencies, and not an indirect manifestation of genetic disorders.
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any genetic screening or testing.2"5 Insurers can only use genetic
information if the results are voluntarily submitted by an applicant,
and the results are favorable to the applicant.2 16 Disability income
insurers and life insurers are not covered under the statutes.
7. California
On September 23, 1994, the California legislature enacted
Senate Bill 1146, Insurance Discrimination: Genetic Character-
221
istics, 2 7 which amended the state's Health and Safety and Insur-
ance Codes.218 When passed, the California statute was one of the
strongest genetic testing laws in the United States due to its
coverage and the "breadth" of its definition of genetic character-
istics. 2 9 According to Senator Patrick Johnston, who sponsored
the legislation for three years, 220 "[t]he issue of discrimination
Id. §§ 1742.42(A), 3901.49(A)(1), 3901.50(A)(1).
215 Id. §§ 1742.42(B), 3901.49(B), 3901.50(B).
216 Id. §§ 1742.42(F), 3901.49(F), 3901.50(F).
217 S.B. 1146, 1993-94 Reg. Sess. (Cal. 1994) (enacted). Most of the
amendments will remain in effect until January 1, 2002, and, as of that date, will
be repealed unless a later enacted statute deletes or extends the January 1, 2002
date. Id.
218 For example, the bill deleted the limitation that "those reasons for refusal
or discrimination be the sole reasons for that refusal or discrimination." See S.B.
1146, 1993-94 Reg. Sess., 1993 Cal. Stat 10123.3, 11512.95 (enacted).
219 The California statute was one of the strongest according to Dr. Paul
Billings, advocate for genetic privacy protections and San Francisco-based
physician who helped author the law. See Sally Lehrman, New California Law
Prohibits Genetic Discrimination by Health Insurers, BIOTECH. NEWSWATCH,
Oct. 17, 1994, at 1; Shulman, supra note 39, at E2. The statute was the first to
cover protein tests. See notes and accompanying text infra p. 607 (comparing the
different state law definitions of "genetic testing").
Under the California law, "genetic characteristics" are defined as "any
scientifically or medically identifiable gene or chromosome, or alteration thereof,
which is known to be a cause of a disease or disorder, or determined to be
associated with a statistically increased risk of development of a disease or
disorder, and which is asymptomatic of any disease or disorder." CAL. HEALTH
& SAFETY CODE § 1374.7(c); CAL. INS. CODE § 10147(b).
220 Lehrman, supra note 219, at 1.
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based on one's genetic traits is becoming an increasing
problem., 221 He warned that "many individuals will choose not
to be tested for the simple reason the test results may be held
against them by potential insurers. "222
The California law prohibits those forms of refusal and
discrimination of insurance by health care service plans,
self-insured employee welfare benefit plans and nonprofit hospital
service plans on the basis of an individual's genetic characteristics
which in certain situations may be associated with disability in that
person or that person's offspring.2 23 The law also prohibits an
insurer licensed to issue disability policies for hospital, medical and
surgical expenses from failing or refusing to accept an application
for that insurance, issuing or cancelling that insurance, charging a
higher rate or premium, or placing a limitation on coverage based
on an individual's genetic characteristics. 224 Further protections
both specify penalties for willful or negligent disclosure of genetic
characteristic test results, 225 and prevent insurers from requiring
genetic tests in order to determine insurability. 226 The law does
not apply to life and disability policies that are "contingent on
review or testing" for illness.
22
"
Recent legislation enacted on October 10, 1995,228 imposes
221 Lawmaker to Present Bill Extending Bar on Gene-BasedDiscrimination,
BNA's HEALTH CARE POL'Y REP., Dec. 5, 1994, at 2007, 2007.
222 Id.
223 CAL. HEALTH & SAFETY CODE § 1374.7(a); CAL. INS. CODE
§§ 10123.3(a), 11512.95(a). A "self-insured employee welfare benefit plan" is
"any plan or program of benefits provided by an employer or an employee
organization, or both for the purposes of providing hospital, medical, surgical,
nursing, or dental services ... ." See CAL. INS. CODE § 10121(0 (West 1993).
A "nonprofit hospital service plan" may include "maintenance and care in the
hospital" and reimbursement for medical services. CAL. INS. CODE § 11493
(West 1988).
224 CAL. INS. CODE § 10140(b).
225 Id. § 10149.1.
226 Id. § 10148.
227 Id. § 10140(b).
228 CAL. INS. CODE §§ 10123.31, 10123.35, 10140.1, 10140.5, 11512.96,
11512.965; CAL. HEALTH & SAFETY CODE § 1374.9 The Insurance Discrimi-
nation: Genetic Characteristics law took effect on January 1, 1996. This
legislation was proposed by Senator Patrick Johnston, sponsor of Senate Bill
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increased penalties for a violation of provisions relating to
discrimination based on an individual's genetic characteristics by
insurers.229 In addition, the law prohibits insurers from offering
separate health care policies to people genetically predisposed to
illness.23 ° This was done to "close a potential loophole," because
there were cases in which applicants were offered bare-minimum
policies with different terms and benefits as a result of their genetic
characteristics.23  According to Senator Johnston, this bill
responded to a situation where "science has outstripped the law and
ethics, and public policy has to come along and account for new
technology." '232
Moreover, on February 22, 1996, Senator Johnston introduced
legislation designed to further strengthen existing California
law.233 The bill would prohibit discrimination in renewal poli-
cies,23 prohibit health care service plans, self-insured employee
welfare benefit plans, some life and disability insurers and
nonprofit hospital service plans from seeking, using or maintaining
"any genetic information for underwriting purposes or for any
nontherapeutic purpose, ' '23' and would replace the term "genetic
characteristics" with "genetic information. '
231
1146.
229 Violations by health care service plans, self-insured employee welfare
benefit plans, life or disability insurers and nonprofit hospital service plans can
now result in administrative penalties of up to $100,000 depending on the
number of violations. CAL. HEALTH & SAFETY CODE § 1374.9(a); CAL. INS.
CODE §§ 10123.31(a)-(c), 10140.5(a)-(c), 11512.96(a)-(c).
230 CAL. HEALTH & SAFETY CODE § 1374.7(a); CAL. INS. CODE
§§ 10123.3(a), 10140(b), 11512.95(a).
231 Cal. Bars Use of Genetic Tendency Data, NAT'L UNDERWRITER, Oct. 23,
1995, at 3.
232 Id
233 S.B. 1740, 1995-96 Reg. Sess. (Cal. 1995).
234 Id. §§ 1374.7(a), 10123.3(a), 11512.95(a).
235 Id. §§ 56.17(h), 10123.35(h), 10140.1(h), 11512.965(h).
236 See S.B. 1740. "Genetic information" is defined as "information about
genes, gene products, or inherited characteristics, that may derive from the
individual or family member." Id. §§ 1374.7(c), 10123.3(c), 10140(f),
11512.95(c). See notes and accompanying text supra pp. 587-88 (discussing the
significance of the term "genetic information" in pending federal legislation).
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8. Colorado
In 1994, the Colorado legislature enacted a legislative
declaration limiting the uses of genetic testing.237 The purpose of
the statute is to protect individual privacy and autonomy with
regard to a person's genetic information. 238 The statute intends to
"prevent information derived from genetic testing from being used
to deny access to health care insurance, group disability insurance,
or long-term care insurance coverage., 239 The statute prohibits
"entities ' '24° from seeking, using, or keeping information derived
from genetic testing for any underwriting purpose connected with
the covered insurance.241 In addition, "information derived from
genetic testing shall be confidential and privileged. 242 Thus, to
release any genetic testing information, the statute requires entities
to obtain "specific written consent" by the person tested.243 These
prohibitions do not apply to life insurance or individual disability
insurance.24
237 COLO. REV. STAT. § 10-3-1104.7. "Genetic testing" is defined as "any
laboratory test of human DNA, RNA [product of DNA], or chromosomes that
is used to identify the presence or absence of alterations in genetic material
which are associated with disease or illness" and only includes tests that directly
measure the alterations. Id. § 10-3-1 104.7(2)(b).
238 Id. § 10-3-1104.7(1)(c).
239 Id. § 10-3-1104.7(1)(d).
240 "Entities" are defined as "any sickness and accident insurance company,
health maintenance organization, nonprofit hospital, medical-surgical and health
service corporation, or other entity that provides health care insurance, group
disability insurance, or long-term care insurance coverage .... " Id.
§ 10-3-1104.7(2)(a).
241 Id § 10-3-1104.7(3)(b).
242 Id § 10-3-1104.7(3)(a).
243 Id. § 10-3-1104.7(3)(a), (5).
244 Id. § 10-3-1104.7(10).
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9. Georgia
On April 21, 1995, the Georgia legislature added a new chapter
on genetic testing to the state's insurance code.245 The legislature
found that it was appropriate to limit the use and availability of
genetic information in order to protect individual privacy and
autonomy, and thus, prohibited insurance companies from seeking
information derived from genetic testing,246 or using information
derived from genetic testing to deny access to accident and sickness
insurance.247 However, the current prohibitions do not apply to
life, disability or health insurance.248 Pending legislation intro-
duced on January 30, 1995, would extend these prohibitions,
providing that information derived from genetic testing could not
be sought or used to deny access to health or disability insurance




On May 16, 1995, the New Hampshire legislature enacted a
new act which limits genetic testing.250 The law prohibits health
insurance providers from requiring or requesting an individual or
family member to undergo genetic testing, 25' revealing if testing
245 GA. CODE ANN. §§ 33-54-1 to 8.
246 Id. § 33-54-1. "Genetic testing" is defined as:
laboratory tests of human DNA or chromosomes for the purpose of
identifying the presence or absence of inherited alterations in genetic
material or genes which are associated with a disease or illness that is
asymptomatic at the time of testing and that arises solely as a result of
such abnormality in genes or genetic material.
Id. § 33-54-2.
247 Id. § 33-54-1.
248 Id. § 33-54-7.
249 S.B. 233, 143d Gen. Assembly, 1995-96 Reg. Sess. (Ga. 1995).
250 N.H. REV. STAT. ANN. §§ 141-H:l to 6. The Genetic Testing law took
effect on January 1, 1996. Id.
251 "Genetic testing" is defined as:
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occurred or any results of a test, conditioning insurance on any
genetic test information or considering genetic testing in the
determination of rates or other aspects of coverage.252 These
provisions do not apply to life, disability income or long-term care
insurance."3 Disclosure of the results or fact that an individual
underwent genetic testing is prohibited without prior written and
informed consent of the individual." 4
11. Minnesota
On June 1, 1995, the Minnesota legislature passed the Genetic
Discrimination Act,255 which regulates the use of genetic testing
by insurers. According to Representative Charlie Weaver, sponsor
of the legislation, the bill was introduced to prevent the danger of
creating an uninsurable "genetic underclass., 25 6 The Act prohibits
a health plan company257  from requiring or requesting an
individual or blood relative to take a genetic test,258 inquiring if
a test, examination or analysis which is generally accepted in the
scientific and medical communities for the purpose of identifying the
presence, absence or alteration of any gene or chromosome, and any
report, interpretation or evaluation of such a test, examination or
analysis, but excludes any otherwise lawful test, examination or
analysis that is undertaken for the purpose of determining whether an
individual meets reasonable functional standards for a specific job or
task.
N.H. REv. STAT. ANN. § 141-H:l.
252 Id. § 141-H:4.
253 Id. § 141-H:5.
254 Id. § 141-H:2.
255 MINN. STAT. ANN. § 72A.139. The Genetic Discrimination Act took
effect on January 1, 1996. Id.
256 Bill Would Prevent Insurers from Using Genetic Tests to Make Coverage
Decisions, STAR TRIB., Jan. 26, 1995, at 2B.
257 A "health plan company" is a health care carrier (insurance company,
nonprofit health service plan, HMO, fraternal benefit society or self-insurance
employee health plan) or an integrated service network (which provides health
services "to enrollees for a fixed payment per time period"). MINN. STAT. ANN.
§§ 62Q.01(4), 62A.0 11(2), 62N.02(8) (West Supp. 1996).
251 "Genetic test" is defined as:
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a genetic test was taken or refused, taking into consideration the
fact of whether a genetic test was taken or refused or taking into
consideration any results of a genetic test, when making any
underwriting decision in connection with the offer, sale or renewal
of a health plan. 25 9 A life insurance company or fraternal benefit
society 260 is permitted to require genetic testing for the purpose
of determining insurability.26' However, the insurer must obtain
written informed consent for the test and must notify the applicant
of any test result.26 2 In addition, an insurance company must pay




On July 19, 1995, the Oregon legislature approved an act
relating to genetics 6.2 ' The Legislative Assembly found that
a presymptomatic test of a person's genes, gene products, or chromo-
somes for the purpose of determining the presence or absence of a
gene or genes that exhibit abnormalities, defects, or deficiencies,
including carrier status, that are known to be the cause of a disease or
disorder, or are determined to be associated with a statistically
increased risk of development of a disease or disorder. "Genetic test"
does not include a cholesterol test or other test not conducted for the
purpose of determining the presence or absence of a person's gene or
genes.
MINN. STAT. ANN. § 72A.139(2)(b).
259 Id. § 72A.139(3).
260 A "fraternal benefit society" is:
[a]ny incorporated society, order, or supreme lodge, without capital
stock ... conducted solely for the benefit of its members and their
beneficiaries and not for profit, operated on a lodge system with
ritualistic form of work or branch system that confines its membership
to any one religious denomination, having a representative form of
government, and which provides benefits ....
MINN. STAT. ANN. § 64B.01 (West 1986).
261 MINN. STAT. ANN. § 72A.139(4).
262 Id § 72A.139(5), (6).
263 Id § 72A.139(7).
264 OR. REV. STAT. §§ 659.700, 659.705, 659.710, 659.715, 659.720,
746.135.
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"[g]enetic information is uniquely private and personal information
that should not be collected, retained or disclosed without the
individual's authorization. 2 65 Thus, providers "may not use
genetic information to reject, deny, limit, cancel, refuse to renew,
increase the rates of, affect the terms and conditions of or otherwise
affect any policy for hospital or medical expenses. 2 66 The statute
also prohibits insurance providers from using favorable tests to
induce the purchase of insurance.2 67 However, the law allows an
insurance provider to ask an applicant to take a genetic test2 68 in
connection with an application for insurance, although specific
authorization from the individual is required.269 In addition, the
DNA sample must promptly be destroyed after the testing.27°
C. Analysis of State Legislation
Table 1 reflects the trend of enacted legislation which restricts
health and life insurers from using an individual's genetic charac-
teristics in the underwriting process. The states are listed according
to the date that their laws were enacted. Restrictions on the use of
genetic information or genetic testing are marked ("X"), and
statutes without restrictions on health and life insurance are blank.
Pending legislation that would restrict the use of genetic infor-
mation by health insurers is also marked.
265 Id. § 659.705(b). According to Senator Bob Shoemaker, who helped
author the law, "[tihe fundamental premise is ... that my genetic characteristics
are my private property and others are not entitled to access [this information]."
It's All in the Genes, INDIANAPOLIS NEWS, Sept. 30, 1995, at A6.
266 OR. REV. STAT. § 746.135(3).
267 Id. § 746.135(2).
261 Id. § 746.135(1). "Genetic test" is defined as "a test for determining the
presence or absence of genetic characteristics in an individual, including tests of
nucleic acids such as DNA, RNA and mitochondrial DNA, chromosomes or
proteins in order to diagnose a genetic characteristic."Id. § 659.700(5). "Genetic
characteristic" is defined as "any gene or chromosome, or alteration thereof, that
is scientifically or medically believed to cause a disease, disorder or syndrome,
or to be associated with statistically increased risk of development of a disease,
disorder or syndrome." Id. § 659.700(3).
269 Id. § 746.135(1).
270 Id. § 659.715(5).
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Table 1. Restrictions on the Use of Genetic Information by Insurers
State Date of Health Life Health
Law Insurance Insurance Insurance
Proposals
Maryland 1986 X X X
Arizona 1989 X
Montana 1991 X
Wisconsin 1991 X X
Florida 1992 X X X
Ohio 1993 X
California 1994 X X X
Colorado 1994 X
Georgia 1995 X
New Hampshire 1995 X
Minnesota 1995 X X
Oregon 1995 X
Source: ARIz. REV. STAT. ANN. § 20-448; CAL. CIV. CODE § 56.17; CAL. INS.
CODE §§ 10123.3,10123.31,10123.35,10140,10140.1,10140.5,10143,10146,
10147, 10148, 10149, 10149.1, 11512.95, 11512.96, 11512.965; CAL. HEALTH
& SAFETY CODE §§ 1374.7, 1374.9; COLO. REV. STAT. ANN. § 10-3-1104.7;
FLA. STAT. ANN. § 760.40; GA. CODE ANN. §§ 33-54-1 to 8; MD. CODE ANN.,
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INS. § 223; MINN. STAT. ANN. § 72A.139; MONT. CODE ANN. § 33-18-206;
N.H. REV. STAT. ANN. §§ 141-H:1 to 6; OHIO REV. CODE ANN. §§ 1742.42,
1742.43, 3901.49, 3901.491, 3901.50, 3901.501; OR. REV. STAT. §§ 659.700,
659.705, 659.710, 659.715, 659.720, 746.135; Wis. STAT. ANN. § 631.89; S.B.
1740, 1995-96 Reg. Sess. (Cal. 1995); S.B. 748, 1996 Reg. Sess. (Fla. 1996);
H.B. 923, 1996 Reg. Sess. (Fla. 1996) (identical bills); S.B. 233, 143d Gen.
Assembly, 1995-96 Reg. Sess. (Ga. 1995); S.B. 276, 1996 Leg. Sess. (Md.
1996); A.B. 227, 92d Leg. Sess., 1995-96 Reg. Sess. (Wis. 1995).
The state statutes reflect a trend giving greater protection to
individuals in the area of health insurance. While three out of the
five states that enacted legislation before 1993 restrict the use of
genetic information for health insurance,27' only Wisconsin has
a comprehensive policy with effective protections. 2  The
Wisconsin legislation prohibits any consideration of genetic
information for medical underwriting.273 Moreover, Wisconsin's
pending legislation, if passed, would give the most expansive
definition yet of "genetic testing., 274 In contrast to these states,
six out of the seven states that enacted legislation after 1992 (most
at the end of 1994 through 1995), give comprehensive protection
to individuals for health insurance. 275 The laws prohibit the
27' Florida, Maryland and Wisconsin do not have effective restrictions on the
use of genetic information for health insurance. See FLA. STAT. ANN. § 760.40;
MD. CODE ANN., INS. § 223; WIs. STAT. ANN. § 631.89.
272 WIS. STAT. ANN. § 631.89. See supra pp. 592-93 (analyzing Wisconsin's
enacted legislation). However, pending legislation in Florida and Maryland would
extend protections against genetic discrimination to individuals for health
insurance. See S.B. 748, 1996 Reg. Sess. (Fla. 1996); H.B. 923, 1996 Reg. Sess.
(Fla. 1996) (identical bills); S.B. 276, 1996 Leg. Sess. (Md. 1996).
273 WIS. STAT. ANN. § 631.89(2).
274 A.B. 227, 92d Leg. Sess., 1995-96 Reg. Sess. (Wis. 1995). See supra p.
593 (analyzing Wisconsin's pending legislation).
275 California, Colorado, Minnesota, New Hampshire, Ohio and Oregon give
comprehensive protection to individuals for health insurance. See CAL. INS. CODE
§§ 10123.3, 10123.31, 10123.35, 10140, 10140.1, 10140.5, 10143, 10146, 10147,
10148, 10149, 10149.1, 11512.95, 11512.96, 11512.965; CAL. HEALTH &
SAFETY CODE §§ 1374.7, 1374.9; COLO. REV. STAT. ANN. § 10-3-1104.7; MINN.
STAT. ANN. § 72A.139; N.H. REV. STAT. ANN. §§ 141-H:1 to 6; OHIO REV.
CODE ANN. §§ 1742.42, 1742.43, 3901.49, 3901.491, 3901.50, 3901.501; OR.
REV. STAT. §§ 659.700, 659.705, 659.710, 659.715, 659.720, 746.135.
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requirement, use or consideration of genetic information for health
insurance coverage.276
The trend in the law also gives less protection, from the already
limited restrictions in place, to individuals in the area of life
insurance. Out of the five states that enacted legislation before
1993, four contain provisions limiting the use of genetic infor-
mation for life insurance.2 77 However, three allow use if there is
"actuarial justification. 2 78 This effectively eliminates protection
because insurance companies would not use genetic information
unless they had an actuarial reason. The fourth, Florida, only
provides for the testing to be repeated if genetic information was
used to deny insurance.279 If the test results are accurate, any
decision based on the information is permitted. In contrast to these
laws, most of the legislation enacted after 1992 does not even
attempt to restrict the use of genetic information for life insur-
ance. 211 California has a provision for life insurance, but the
restrictions are limited to small and group life insurance policies
that are not contingent upon medical testing.28' In addition,
Minnesota's provision only requires that life insurers obtain a
276 SeeCAL. INS. CODE §§ 10123.3(a), 10140(b), 10148, 11512.95(a); CAL.
HEALTH & SAFETY CODE § 1374.7(a); COLO. REV. STAT. ANN.
§ 10-3-1104.7(3)(b); MINN. STAT. ANN. § 72A.139(3); N.H. REV. STAT. ANN.
§ 141-H:4; 01-o REV. CODE ANN. §§ 1742.42(B), 3901.49(B), 3901.50(B); OR.
REV. STAT. § 746.135(3). Although Georgia does not have any restrictions
concerning health insurance, a pending bill, S.B. 233, 143d Gen. Assembly,
1995-96 Reg. Sess. (Ga. 1995), would extend protection.
277 Arizona, Florida, Maryland and Montana have laws restricting the use of
genetic information for life insurance. See ARIZ. REV. STAT. ANN. § 20-448;
FLA. STAT. ANN. § 760.40; MD. CODE ANN., INS. § 223; MONT. CODE ANN.
§ 33-18-206.
278 Arizona, Maryland and Montana allow the use of genetic information for
life insurance if there is an actuarial reason. See ARZ. REV. STAT. ANN.
§ 20-448; MD. CODE ANN., INS. § 223; MONT. CODE ANN. § 33-18-206. See
supra pp. 589-92 (analyzing these laws).
279 FLA. STAT. ANN. § 760.40(3).
280 See notes and accompanying text supra pp. 595-603 (discussing the scope
of genetic discrimination laws enacted after 1992).
21 CAL. INS. CODE § 10140(b). See Lehrman, supra note 219, at 1.
606
GENETIC DISCRIMINATION
written informed consent for the genetic test and that they notify
the applicant of the test results.28 2
The definitions of "genetic testing" for the state laws have also
become more comprehensive over time. Three out of the five
genetic discrimination statutes enacted before 1993 do not even
contain the term "genetic testing. 2 3 Although Florida's statute
includes the term, "genetic testing" is not specifically defined.28 4
In addition, four states, which did enact laws defining "genetic
testing, 2" do not prohibit discrimination based on gene protein
tests because "proteins" are not covered under the definitions.28 6
However, four more states have enacted statutes with compre-
hensive definitions of "genetic testing" or "genetic character-
istics, ' 28 7 and three of these states were the latest to enact genetic
discrimination laws.28 These laws cover tests performed using
genes or gene products.8 9
282 MINN. STAT. ANN. § 72A.139(5), (6).
283 Arizona, Maryland and Montana's statutes do not contain the term
"genetic testing." See ARiz. REv. STAT. ANN. § 20-448; MD. CODE ANN., INS.
§ 223; MONT. CODE ANN. § 33-18-206.
284 See FLA. STAT. ANN. § 760.40(1).
285 Colorado, Georgia, Ohio and Wisconsin define the term "genetic testing"
in their statutes. See COLO. REV. STAT. § 10-3-1104.7; GA. CODE ANN. § 33-54-
2; OHIO REV. CODE ANN. §§ 1742.42, 3901.49, 3901.50; WIS. STAT. ANN.
§ 631.89.
286 See COLO. REV. STAT. § 10-3-1104.7; GA. CODE ANN. § 33-54-2; OHIO
REV. CODE ANN. §§ 1742.42(A), 3901.49(A), 3901.50(A); WIs. STAT. ANN.
§ 631.89. See supra notes 237, 246, 214, 191 (providing the definition of
"genetic testing" for the respective statutes).
287 These states include California, Minnesota, New Hampshire and Oregon.
See CAL. HEALTH & SAFETY CODE § 1374.7(c); CAL. INS. CODE § 10147(b);
MINN. STAT. ANN. § 72A.139(2)(b); N.H. REV. STAT. ANN. § 141-H:l; OR.
REV. STAT. § 659.700(5). See supra notes 219, 258, 251, 268 (providing the
definition of "genetic testing" or "genetic characteristics" for the respective
statutes).
28 These states include Minnesota, New Hampshire and Oregon, each
enacting their genetic discrimination statutes in 1995.
289 See CAL. HEALTH & SAFETY CODE § 1374.7(c); CAL. INS. CODE
§ 10147(b); MINN. STAT. ANN. § 72A.139(2)(b); 1995 N.H. Laws 101 § 141-
H:1; OR. REV. STAT. § 659.700(5). See supra notes 219, 258, 251, 268
(providing the definition of "genetic testing" or "genetic characteristics" for the
respective statutes).
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The trend of the law, affording greater protections to
individuals for health insurance and lesser protections for life
insurance, is consistent with social policy considerations.
Historically, more life insurance policies have been medically
underwritten than health insurance policies, and fewer Americans
believe life insurance is a basic right.29 ° In addition, adverse
selection plays an important role when considering life insurance
and genetic information.291 If an individual learns of the likeli-
hood or certainty of getting a genetic disease, and then purchases
large amounts of life insurance, there is a potential for "significant
economic losses by insurers. 292 However, it is unlikely that a
person will purchase health insurance solely on the basis of their
genetic makeup.293 Many people who purchase health insurance
will not suffer from genetic disease, but they obtain health
insurance because it covers a wide variety of ailments. 294 Factors
including environmentally-caused diseases, accidents, injuries and
maternity costs, all give incentives for purchasing health insurance
long before the discovery of any genetic disease.295 Health
insurance is a necessary protection against these ailments. Thus,
preventing insurers from considering genetic information in health
insurance underwriting is both fair and appropriate.
290 ASSESSNG GENETIC RISKS, supra note 2, at 280. For a discussion of the
distinctions between health and life insurance, see Meyer, supra note 46, at 1293-
94; see also Thomas H. Murray, Genetics and the Moral Mission of Health
Insurance, HASTINGS CTR. REP., Nov.-Dec. 1992, at 12, 14-15 (discussing the
right to health insurance and life insurance).
291 "Adverse selection" occurs when people believe themselves to be at a
high risk. Thus, they are inclined "to seek insurance or to keep insurance in force
...." THOMSETT, supra note 185, at 8. See Kenneth S. Abraham & Lance
Liebman, Private Insurance, Social Insurance, and Tort Reform: Toward a New
Vision of Compensation for Illness and Injury, 93 COLUM. L. REV. 75, 102-03
(1993) (discussing adverse selection in the context of disability insurance);
Alexander M. Capron, Hedging Their Bets; Genetic Testing and Life Insurance,
HASTINGS CTR. REP., May 1993, at 30 (discussing genetic testing, life insurance
and adverse selection).
292 Joseph M. Miller, Comment, Prevent Discrimination Based on the "Luck







Federal and state legislatures are beginning to address the
problem of genetic discrimination. Although many states have
recently enacted comprehensive laws, the vast majority must now
recognize that, since September 1995, general population screenings
for genetic disorders are possible." Thus, the enactment of
legislation regulating genetic information can no longer wait. New
genes are constantly being discovered,297 and genetic tests can
now pinpoint those of us predisposed to disease. Insurance
companies will use this information to our detriment. According to
one commentator, "[i]nsurance is a method of risk-sharing against
the unknown, and the more the unknown becomes knowable in
advance, the less the current system makes sense. We need to think
of ways of restructuring our insurance system.., to accommodate
this ability to predict future risks. 2 9' Legislation preventing the
use of genetic information in medical underwriting is the way to
accommodate this ability to predict future risks. Although there are
other insurance mechanisms whereby genetic information would not
be needed,299 until they are implemented, state and federal
296 In September 1995, researchers discovered a genetic defect in a gene
associatedwith familial breast cancerthat had an unusual frequency in American
Ashkenazi Jews. Kolata, supra note 41, at A24. Moreover, in December 1995,
another breast cancer gene was disclosed. Kolata, supra note 41, at B 18. Greatly
improved genetic screening can now be offered to women. Kolata, supra note 41,
at B 18. See supra note 41 (discussing general population screenings).
297 See supra notes 37-41 and accompanying text (discussing new gene
discoveries and causes of genetic disease).
298 Weiss, supra note 122, at A3 (quoting Professor Mark Rothstein, Director
of the University of Houston Health Law and Policy Institute).
299 One alternative system in which medical underwriting would not be
necessary, and thus genetic information would not be needed, is universal health
care. See supra note 98 (discussing universal health care). Another mechanism
is for states to individually organize health care for all of its citizens. See Martin
Gottlieb, A Managed Care Cure-All with Flaws and Potential, N.Y. TIMES, Oct.
1, 1995, at 1 (explaining Tennessee's approval of health care measures which
give health insurance to every uninsured person who wants it); see also Jerry L.
Mashaw & Theodore R. Marmor, The Case for Federalism and Health Care
Reform, 28 CONN. L. REv. 115 (1995) (discussing state-led health care reform).
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legislation is needed to keep an individual's genetic information
strictly private, and out of the hands of health insurers.
